Infants of diabetic mothers are known to be at an increased risk of congenital heart disease and increased rates of asymmetric cardiac hypertrophy. Currently, it is unknown whether the adverse intrauterine environment created by gestational diabetes may having lasting effects on cardiac function in hearts that are presumed "normal" from birth or have resolved hypertrophy. We hypothesized that being an offspring of a diabetic mother (ODM) would have negative long term sequela on cardiovascular function. Pregnant rats were injected with either 50 mg/kg streptozotocin or buffer on day 12 of gestation to induce diabetes and had their glucose levels controlled by twice daily insulin given on a sliding scale. All offspring were fostered by healthy dams. At 10 months of age, hearts were studied in an isolated, working heart preparation with a 30 minute ischemia and 2.5 hour reperfusion period. Rate pressure product (RPP) (left ventricular developed pressure ϫ heart rate; bpm*mmHg), maximum generated change in pressure per time (max dP/dT; mmHg/s), a measure of systolic function, and minimum generated change in pressure per time (min dP/dT; -mmHg/s), a measure of diastolic function, were calculated. Female animals in both the control (C) and ODM groups showed a decrease in heart function after ischemia/reperfusion (I/R) injury (RPP preischemia (PI): C 10.33 Ϯ 1.67, ODM 11.11 Ϯ 0.66; 2.5h: C 3.49 Ϯ 0.71, ODM 3.85 Ϯ 0.58; max dP/dT PI: C 1.25 Ϯ 0.18, ODM 1.66 Ϯ 0.32; 2.5h: C 0.41 Ϯ 0.07, ODM 0.54 Ϯ 0.11; min dP/dT PI: C 0.90 Ϯ 0.15, ODM 0.96 Ϯ 0.05, 2.5h: C 0.36 Ϯ 0.06, ODM 0.43 Ϯ 0.06). Male control hearts showed a response to I/R injury similar to female hearts (RPP PI: 11.29 Ϯ 3.66; 2.5h: 1.62 Ϯ 0.52; max dP/dT PI: 1.30 Ϯ 0.31; 2.5h: 0.17 Ϯ 0.04; min dP/dT PI: 0.79 Ϯ 0.21; 2.5h: 0.14 Ϯ 0.04). In contrast, preischemic cardiac function was significantly depressed in male ODM and showed no significant change following I/R injury (RPP PI: 6.41 Ϯ 1.01; 2.5h: 4.14 Ϯ 1.15; max dP/dT PI: 0.71 Ϯ 0.14; 2.5h: 0.49 Ϯ 0.18; min dP/dT PI: 0.45 Ϯ 0.08; 2.5h: 0.36 Ϯ 0.10). These data demonstrate significant differences between long term physiologic effects on the hearts of offspring of diabetic mothers depending on gender. Male offspring of diabetic mothers have decreased function at baseline compared to their female counterparts; however, they have "protection" from further decreased function in response to ischemia/reperfusion injury.
ISOLATED WORKING HEARTS OF OFFSPRING OF DIABETIC RATS DEM-ONSTRATE PHYSIOLOGIC DIFFERENCES IN RESPONSE TO ISCHEMIA/ REPERFUSION INJURY
MM Agoudemos, JL Segar, TD Scholz. University of Iowa Children's Hospital Iowa City, IA.
Infants of diabetic mothers are known to be at an increased risk of congenital heart disease and increased rates of asymmetric cardiac hypertrophy. Currently, it is unknown whether the adverse intrauterine environment created by gestational diabetes may having lasting effects on cardiac function in hearts that are presumed "normal" from birth or have resolved hypertrophy. We hypothesized that being an offspring of a diabetic mother (ODM) would have negative long term sequela on cardiovascular function. Pregnant rats were injected with either 50 mg/kg streptozotocin or buffer on day 12 of gestation to induce diabetes and had their glucose levels controlled by twice daily insulin given on a sliding scale. All offspring were fostered by healthy dams. At 10 months of age, hearts were studied in an isolated, working heart preparation with a 30 minute ischemia and 2.5 hour reperfusion period. Rate pressure product (RPP) (left ventricular developed pressure ϫ heart rate; bpm*mmHg), maximum generated change in pressure per time (max dP/dT; mmHg/s), a measure of systolic function, and minimum generated change in pressure per time (min dP/dT; -mmHg/s), a measure of diastolic function, were calculated. Female animals in both the control (C) and ODM groups showed a decrease in heart function after ischemia/reperfusion (I/R) injury (RPP preischemia (PI): C 10.33 Ϯ 1.67, ODM 11.11 Ϯ 0.66; 2.5h: C 3.49 Ϯ 0.71, ODM 3.85 Ϯ 0.58; max dP/dT PI: C 1.25 Ϯ 0.18, ODM 1.66 Ϯ 0.32; 2.5h: C 0.41 Ϯ 0.07, ODM 0.54 Ϯ 0.11; min dP/dT PI: C 0.90 Ϯ 0.15, ODM 0.96 Ϯ 0.05, 2.5h: C 0.36 Ϯ 0.06, ODM 0.43 Ϯ 0.06). Male control hearts showed a response to I/R injury similar to female hearts (RPP PI: 11.29 Ϯ 3.66; 2.5h: 1.62 Ϯ 0.52; max dP/dT PI: 1.30 Ϯ 0.31; 2.5h: 0.17 Ϯ 0.04; min dP/dT PI: 0.79 Ϯ 0.21; 2.5h: 0.14 Ϯ 0.04). In contrast, preischemic cardiac function was significantly depressed in male ODM and showed no significant change following I/R injury (RPP PI: 6.41 Ϯ 1.01; 2.5h: 4.14 Ϯ 1.15; max dP/dT PI: 0.71 Ϯ 0.14; 2.5h: 0.49 Ϯ 0.18; min dP/dT PI: 0.45 Ϯ 0.08; 2.5h: 0.36 Ϯ 0.10). These data demonstrate significant differences between long term physiologic effects on the hearts of offspring of diabetic mothers depending on gender. Male offspring of diabetic mothers have decreased function at baseline compared to their female counterparts; however, they have "protection" from further decreased function in response to ischemia/reperfusion injury.
LEUKOTRIENE B 4 MEDIATES DIABETES-INDUCED RETINAL MICRO-VASCULAR ENDOTHELIAL CELL DYSFUNCTION
R Gubitosi-Klug, R Talahalli. Rainbow Babies and Children's Hospital and Case Western Reserve University Cleveland, OH.
Diabetic mice deficient in leukotriene production develop less capillary degeneration, a hallmark characteristic of diabetic retinopathy. Cultured mouse retinal microvascular endothelial cells (mREC) were used to further understand the cellular mechanisms by which leukotrienes participate in endothelial cell dysfunction in diabetic retinopathy. mREC were cultured either in physiologic glucose or diabetic-range glucose concentrations. We investigated the role of leukotriene B 4 (LTB 4 ) administration on high glucose-induced alterations in 1) parameters of chronic inflammation including nuclear translocation of NF-kappaB, expression of intracellular adhesion molecule 1 (ICAM 1), and expression of enzymes and receptors in the leukotriene signaling cascade, 2) superoxide generation, and 3) endothelial cell death. Administration of leukotriene B 4 to mREC increased the total expression of the p65 subunit of NF-KappaB, with a larger portion in the nuclear fraction, and increased mREC expression of ICAM-1, mimicking the effects of culturing in high glucose. The addition of LTB 4 in the presence of U75302, a LTB 4 receptor competitive antagonist, inhibited NF-KappaB translocation as well as ICAM-1 enhanced expression. mREC cultured in diabetic-range glucose concentrations expressed a two-fold increase in the LTB 4 receptor, BLT1, compared to mREC cultured in physiologic glucose. (p Ͻ 0.005) High glucose exposure induces a four-fold increase in superoxide generation by mREC. A similar rise in superoxide production was observed following LTB 4 addition to mREC cultured in the presence of physiologic glucose. Endothelial cell death was observed in mREC cultured in high glucose and was increased by the addition of LTB 4 . The cumulative cell death from high-glucose and LTB 4 was reversed when cultures were pre-treated with U75302. (p Ͻ 0.005) LTB 4 induces diabetes-like pro-inflammatory changes in cultured mouse retinal microvascular cells and is a potential mediator of endothelial cell dysfunction in diabetic retinopathy.
ROLE OF CHEMOKINE RECEPTOR CCR5 ON NAÏVE, T CELL FOR MEM-ORY FORMATION AND TUMOR REJECTION
AY Huang, D Barkauskas, R Liou, J Myers, J Nthale, C Su, C Tong. Rainbow Babies & Children's Hospital University Hospitals Case Medical Center Cleveland, OH.
Purpose of Study: Proper immune function relies on precise timing and sequence of individual cellular interaction in vivo. Using 2-photon microscopy, we have previously observed that inflammatory chemokines, CCL3 (MIP1␣) and CCL4 (MIP1␤), are critically involved in helper T celldependant CD8
ϩ T cell memory generation. CD8 ϩ T cells accomplish this by transient expression of the cognate chemokine receptor, CCR5. Our present research contains three specific aims: A) Investigate mechanisms of transient surface CCR5 expression on naïve T lymphocytes in inflamed lymph node (LN); B) Interrogate functional consequences of naïve T cells upon ligation of CCR5 prior to TCR engagement; C) Examine efficacy of incorporating CCL3 and CCL4 into tumor vaccines to generate systemic anti-tumor immunity. Methods Used: Naïve (CD45.2 ϩ /CD62L hi /CD44 lo /CD69 lo ) T cells were transferred into congenic (CD45.1 ϩ ) recipient mice previously immunized with CpG. Draining LNs were harvested at various times post transfer to analyze T cells for CCR5 expression by flow cytometry. The same cells were also analyzed using histology, in vivo functional assays, and 2-photon microscopy. Concurrently, colon tumor cell line, CT26, was engineered to express CCL3 and/or CCL4. These cell lines were either injected live into naïve recipient to monitor for primary tumor rejection, or irradiated and injected into recipient mice to boost anti-tumor immune response against subsequent lethal tumor challenge. Summary of Results: We observed preferential translocation of pre-formed intracellular CCR5 pool to the cell surface of naïve T cells within inflamed milieu, and that such enhanced expression can be induced by direct TCR contact with self-peptide/ MHC. Naïve cells with enhanced CCR5 expression exhibited increased expansion and effector function upon antigenic stimulation. Finally, tumors engineered to secrete CCL3 exhibited enhanced primary rejection and systemic anti-tumor memory T cell immunity. Conclusions Reached: Our study provided a novel role for inflammatory chemokines in immune memory generation. Future studies will involve proteomic and genomic profiling for factors critical in this process. We will also interrogate chemokine-assisted cellular recruitment, interaction, and functional development within tumor microenvironment. Enhanced understanding of these cellular and molecular events holds promise for rational design of immunotherapeutic strategies against cancer and immune-mediated disorders.
FOLATE PATHWAY POLYMORPHISMS IN JUVENILE IDIOPATHIC AR-THRITIS
ML Becker, R Gaedigk, A Lasky, B Schindel, JS Leeder. Children's Mercy Hospital Kansas City, MO.
Purpose: Several studies have investigated the effect of genetic variation in folate pathway genes on methotrexate (MTX) toxicity and response in adult RA and pediatric oncology. The purpose of this study was to explore the relationship between genetic variation in a set of genes involved in the cellular uptake (RFC-1 also known as SLC19A1), activation (FPGS, GGH), retention (ABCG2) and therapeutic activity (ATIC, MTHFD2 and TYMS) of MTX in a cohort of JIA patients. Methods: After obtaining informed consent, 5 ml of blood was obtained from JIA patients maintained on a stable dose of MTX for 3 months or longer. Demographic characteristics, efficacy data and toxicity outcomes were collected by chart review. Genomic DNA was extracted from whole blood with the Illustra RNAspin Mini RNA Isolation Kit (GE Healthcare) and amplified in gene specific PCR reactions. A total of 15 allelic variants in 7 genes were assessed by direct sequencing (ABCG2 and ATIC) on a MegaBACE 500 capillary sequencer, by restriction fragment length polymorphism (SLC19A1, FPGS, GGH, MTHFD2) or by size variation detected in direct gel analysis (TYMS) . Associations between genotype and outcome was performed using Chi-square analysis or Fisher's exact test and, where applicable, logistic regression controlling for NSAID and TNF use. Outcomes measured included: the presence of active joints, GI toxicity, and LFT abnormality. Results: Sixty seven subjects with JIA were enrolled. Allele frequencies for all 15 gene variants analyzed were in Hardy Weinberg equilibrium. Genotype frequencies between MTX responders (no active joint involvement) and non-responders (1 or more active joints) were compared. A similar analysis was conducted for toxicity endpoints. The only statistically significant association was between ABCG2 -15994 CϾT (rs7699188) and protection against GI side effects (2-sided Fisher's Exact Test p ϭ .023); the association remained significant (p ϭ .041) after controlling for concurrent medication use (NSAID/TNF) with logistic regression. Due to the large number of comparisons, this result may only be significant due to chance. Conclusions: No allelic variation in any single folate pathway gene was associated with MTX efficacy and toxicity. Given that response to MTX (efficacy and toxicity) is a complex phenotype involving multiple gene products, we conclude that genotype analysis may be too far removed from the clinical phenotypes of interest. Therefore, future studies should be directed at characterizing interindividual variability at more proximal levels, including mRNA, enzyme activities and/or cellular MTX and folate concentrations to develop more useful biomarkers of MTX response.
A DOUBLE-BLINDED RANDOMIZED CONTROLLED TRIAL FOR THE MANAGEMENT OF PEDIATRIC COMMUNITY-ACQUIRED SKIN AB-SCESSES-TO TREAT OR NOT TO TREAT WITH ANTIBIOTICS
M Duong, J Peter, D Halloran, S Barenkamp. Cardinal Glennon Children's Medical Center, St Louis, MO.
Purpose: Determine the utility of antibiotic (abx) in the management of skin abscess following I&D. Methods: This is a double-blind, randomized controlled trial at an urban pediatric emergency department. Sample size (161) was based on a threshold equivalence of 7% (␣ ϭ 0.05, power ϭ 80%). Inclusion criteria: non-toxic, immunocompetent, 3 months to 18 years old, English-speaking patients (pts) with clinical or ultrasound identified skin abscesses who were not on abx. Pts were block randomized to receive placebo or trimethoprim/sulfamethoxazole for 10 days following I&D. Follow-up was a call at 2-3 days & a repeat visit or call at 10 -14 days. Treatment (tx) failure: persistent erythema, tenderness, and/or draining lesions. New lesion: primary resolution with development of an abscess at a different location. Compliance was evaluated by the return of the study medication or by pt report. Results: One hundred and sixty-one patients enrolled (12 lost to follow-up). Main pathogens: CA-MRSA (119, 80%) with 15% clindamycin resistance, methicillin-sensitive Staphylococcus aureus (13, 9%), Proteus mirabilis (6, 4%) & Group A streptococcus (2, 1%).Overall tx failure rate was 5% (7/149) -4/76 on placebo (5%) & 3/73 on abx (4%) (RR ϭ 0.99, 95%CI 0.93, 1.06). New lesions occurred in 28 pts (19%) -18 on placebo (25%) & 10 on abx (14%) (RR ϭ 0.87, 95%CI 0.75, 1.04). Ninety-nine patients (66%) took Ͻ 50% of the medication -54 on placebo & 45 on abx. In this compliant population, tx failure rate was 2/54 on placebo and 0/45 on abx (RR ϭ 0.96, 95%CI 0.97, 1.03). New lesions occurred in 14 pts-12/54 on placebo and 2/45 on abx (RR ϭ 0.81, 95%CI 0.74, 0.96). Conclusion: After I&D of skin abscesses in children, antibiotics do not appear to be helpful in resolving the primary lesion but may be beneficial in preventing the appearance of new lesions. Larger trials are needed to validate these results.
DIFFERENTIAL MECHANISMS FOR CD4؉ AND CD8؉ MEDIATED IN-FLAMMATION IN THE DEVELOPMENT OF EXPERIMENTAL IDIO-PATHIC PNEUMONIA SYNDROME
E Pierce, A Jennings, S Eid, D Askew, KR Cooke. Rainbow Babies and Children's Hospital, Cleveland, OH.
Idiopathic pneumonia syndrome (IPS) is a frequently fatal complication following allogeneic bone marrow transplantation (allo-BMT). The pathophysiology of IPS is complex and involves both soluble and cellular effectors. We hypothesized that donor T cell-mediated injury during IPS involves the generation of cytolytic T lymphocytes (CTL). We examined the role of CTL effector function in the development of IPS using wellestablished murine BMT models. In initial experiments, lethally irradiated B6D2F1 (F1) mice received BMT from either allogeneic C57Bl/6 (B6) or syngeneic (F1) donors. Mice were subsequently analyzed for the development of IPS and for donor T cell chimerism, cytokine phenotype, CTL activity in the lungs at specified points after BMT. At week six, assessment of lung pathology demonstrated that allo-BMT recipients developed significant pulmonary inflammation compared to syngeneic controls (6.6 Ϯ 0.4 vs. 0.3 Ϯ 0.1; p Ͻ 0.01). Donor T cell chimerism in the lung was complete by 2 weeks after BMT and RT-PCR analysis in combination with intra-cytoplasmic staining showed that pulmonary CD4ϩ and CD8ϩ T cells had a Th1/Tc1 phenotype; T cells expressed IFNg, TNFa and RANTES but not IL-4 or IL-5. Chromium release assays showed significant CTL activity mediated by both perforin (39%, 17%) and Fas (51%, 29%) at week 2 and 6 after BMT respectively (data ϭ mean % killing at an effector-target ratio of 48:1). These findings correlated with increased mRNA expression of both perforin and FasL in allo-BMT mice at week 2 compared to controls. In order to ascertain the specific contribution of each cytolytic pathway, F1 animals received allo-BMT from either wild type (WT) B6 donors or from mice deficient in either perforin (pfp -/-) or FasL (gld). Recipients of gld, but not pfp -/-BMT developed significantly less lung injury compared to allo-controls (4.0 Ϯ 0.7 vs. 7.3 Ϯ 0.3 p Ͻ 0.01) as well as reductions in BAL fluid cellularity, CD4ϩ and CD8ϩ T cells, and TNFa levels (p Ͻ 0.05). Further studies using strain combinations wherein donor and host mice are either MHC class I (CD8ϩ mediated IPS) or MHC class II (CD4ϩ mediated IPS) disparate and additional donor mice lacking TNFa revealed that CD4ϩ cells use both FasL and TNFa whereas CD8ϩ T cells use TNFa exclusively during the evolution of IPS. We conclude that pulmonary CTL activity is present during the development to IPS and that differential pathways for cell-mediated cytolysis are used by CD4ϩ and CD8ϩ T cells in this setting.
ONCOSTATIN M, AN INFLAMMATORY CYTOKINE, PROMOTES CLONOGEN-ESIS OF MYELOPOIETIC PROGENITORS IN UMBILICAL CORD BLOOD
K Westbrook, J Ghatak, JM Koenig. Division of Neonatology, Department of Pediatrics, Saint Louis University, St. Louis, MO.
Background: Activated tissue neutrophils release cytokines that promote the attraction of circulating neutrophils to an inflammatory site. Whether neutrophils can promote myelopoiesis during inflammation in an autocrine fashion has not been investigated, although the primarily erythropoietic fetal liver can generate neutrophils during inflammation. Oncostatin M (OSM), a recently-characterized cytokine produced by immune cells, was shown to support the hematopoietic microenvironment in fetal liver. Based on our observations of robust OSM elaboration by stimulated neutrophils, we hypothesized that OSM might augment neutrophil production, potentially contributing to the development of chronic inflammation. Objective/Methods: We designed a set of studies to examine the dose-dependent effects of OSM on myelopoiesis in umbilical cord blood (UCB) CD34ϩ cells. Mononuclear cells isolated from UCB by density centrifugation were enriched for the CD34ϩ fraction by immunomagnetic separation. CD34-enriched cells were plated in duplicate in methylcellulose cultures (MC) containing rh-OSM (0 -100 ng/mL) or a positive control, MC containing a myeloid growth factor (GF) cocktail (Stem Cell, Inc.) without OSM. To assess an additive effect, OSM (100 ng/mL) was added to MC ϩ GF cocktail. After 10 -12 days, plates were scored for myeloid colony formation (CFU-GM), then washed for cell enumeration. Data are reported as the mean (X Ϯ SD) of three separate experiments; analysis was by one-way ANOVA or Student t-test. Results/Conclusion: We observed an OSM dose-dependent increase in the number of CFU-GM colonies derived from CD34ϩ hematopoietic progenitor cells, with the highest average number of observed colonies (29 Ϯ 25 CFU-GM/10 3 plated cells, p Ͻ 0.01, one-way ANOVA) in the presence of 100 ng OSM/mL (n ϭ 4 separate experiments). The mean number of cells per plate also increased in a dose dependent number. Clonogenesis was increased by 33% when OSM (100 ng/mL) was added to a standard cocktail of myeloid growth factors (168 Ϯ 2 vs. 126 Ϯ 6 CFU-GM/10 3 plated cells, p Ͻ 0.001). We conclude that OSM independently induced myelopoiesis and promoted the proliferation of CFU-GM in UCB CD34 cells. In addition, OSM had an additive effect in the presence of myeloid-specific growth factors. These data suggest that inflammatory neutrophils may have the capacity to augment myelopoiesis in addition to promoting neutrophil egress into inflammatory sites. Background: Naïve T cells require balanced signaling through T cell receptors and coreceptors for T cell activation to maintain homeostasis and to mature after antigen recognition. To characterize better the impairment in naïve T cell expansion capacity in HIV infection, we examined the phenotype and activation status of naïve CD4ϩ T cells after TCR engagement. Methods: PBMC obtained from 9 healthy controls and 20 HIVϩ volunteers were depleted of CD45ROϩ cells using magnetic microbeads, then stimulated with anti-CD3 moAb. After 2 days of culture, cells were surface stained with antibodies to CD4, CD27, CD28, CCR7, and CD31 and Ki67 and examined using multi-color flow cytometry. Naïve CD4 T cells were defined as CD45RO/CD4ϩ/CD27ϩ/CD28ϩ/CCR7ϩ/ CD31ϩ or CD31-. Results: Naïve CD4ϩ T cells from HIVϩ individuals displayed impaired entry into cell cycle as reflected in impaired induction of Ki67 expression after TCR stimulation (20.2% (Ϯ5.9 SEM) vs. 9.6% (Ϯ1.8 SEM, p ϭ 0.034). In addition, TCR-activated naïve CD4ϩ T cells from HIVϩ persons increased surface expression of the co-receptors CD27 and CD28 significantly less than cells from healthy donors (p ϭ 0.01). Induction of CD27 and CD28 was directly related to the induction of Ki67 (Spearman's r ϭ 0.95, p ϭ 0.0015) among naïve CD4ϩ T cells from healthy donors. In contrast, a significant correlation between these indices was not observed in naïve CD4ϩ T cells from HIV-infected persons (r ϭ -0.16, p ϭ 0.50), unless CD31-cells were excluded from analysis. These differences likely stemmed from an inability of CD31-cells to express Ki67 after stimulation even though these cells could increase cell surface expression of CD27/CD28. Conclusions: Naïve CD4ϩ T cells in HIVϩ persons fail to upregulate coreceptors for T cell activation CD28 and CD27 after TCR stimulation. Failure of costimulatory pathways likely contributes to the naïve T cell expansion failure that characterizes HIV infection and may determine both failure of naïve T cell homeostasis in HIV infection and impaired generation of memory/effector CD4ϩ T cells after antigen recognition.
FAILURE OF CO-STIMULATORY PATHWAYS AND NAIVE CD4؉ T CELL EXPANSION IN HIV DISEASE
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HYPERGLYCEMIA AS A RISK FACTOR FOR THE DEVELOPMENT OF RETINOPATHY OF PREMATURITY
S Mohamed, E Ahrens, T Colaizy, J Murray, J Dagle. University of Iowa Children's Hospital, Iowa City, IA.
Background: Retinopathy of prematurity (ROP) is a proliferative vascular disorder of the retina that can lead to vision impairment or complete vision loss in premature infants. Low birth weight infants or those that are born at a lower gestational age are particularly vulnerable to develop ROP. There is currently evidence that hyperglycemia may be a risk factor for the development of ROP.
Objective: To analyze the effect of hyperglycemia as a risk factor for the development of moderate to severe ROP. Design/Methods: A prospective cohort study of infants less than 32 weeks who were admitted to the NICU at the University of Iowa Children's Hospital was performed. Initial univariate analysis was performed using Chi-square analysis and simple logistic regression to determine risk factors for ROP. A multiple logistic regression model was then created incorporating these factors to determine the effect of hyperglycemia on the development of moderate to severe ROP. SAS v. 9.1.3 was used for all analyses. Results: There were 347 infants less than 32 weeks gestation available for study, with information available for 330. There were 184 males (55%) and 146 females (45%). 228 subject had no ROP, 40 had stage I ROP, 35 had stage II ROP, and 27 had stage III ROP. No subject had stage IV or V ROP. Univariate analysis demonstrated that gestational age (p Ͻ 0.0001), presence of a patent ductus arteriosus (PDA) (p Ͻ 0.0002, OR 2.5 (CI 1.54-4.05)), days on oxygen (p Ͻ 0.0001, OR 1.016 (CI 1.010-1.022)), and days of glucose greater than 150 (OR 1.161, CI (1.098-1.228)) were associated with the development of ROP. Weight appropriate for gestational age, intraventricular hemorrhage, and gender were not significantly associated with the development of ROP. When gestational age, presence of a PDA, and days of glucose greater than 150 were incorporated into a multiple logistic regression model, days of glucose greater than 150 was significantly associated with the development of moderate to severe ROP (stage II -III) (p ϭ 0.0002). Significance of days of glucose greater than 150 was decreased when days on oxygen was included into the model (p ϭ 0.09). Discussion: Our data suggests that hyperglycemia may play a role in the development of moderate to severe ROP. Further study on a larger patient population will be required to fully investigate the impact of hyperglycemia on the development of ROP.
HUMAN P-GLYCOPROTEIN REDUCES BILIRUBIN-INDUCED CELL DEATH IN VITRO
A Azzuqa, M J Daood, J F Watchko (Sponsoredby Jon F Watchko). Division of Newborn Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine and Magee-Womens Research Institute, Pittsburgh, PA.
Background: Transporters play a critical role in protecting cells from xenobiotics and toxins. Evidence demonstrates multidrug resistance-associated protein 1 (MRP1) protects against bilirubininduced cytotoxicity. The human multidrug resistance transporter P-glycoprotein (Pgp) may also provide cytoprotection against bilirubin-induced cell death. Objective: Characterize the unconjugated bilirubin (UCB) exposure conditions (concentration and duration) that lead to cytotoxicity in human HL-60 cells and assess the potential cytoprotective role of Pgp. Design/Methods: Human HL-60 parent cells (express MRP1 but no Pgp) and HL-60/VCR cells (express Pgp but no MRP1) were studied in vitro under control conditions (no bilirubin) and during 24 and 48 hr exposure to 3 different UCB concentrations (0.5, 1 and 2 M). UCB cytotoxicity was assessed using: 1) trypan blue staining (cell viability), 2) fluorescent microscopy of morphological changes of apoptosis (nuclear condensation and fragmentation) and necrosis using Hoechst 33342 and propidium iodide stains, and 3) flow cytometry analysis of cell viability. Results: Cell viability and proliferation were affected by UCB as they were decreased in HL-60 parent cells as contrasted with HL-60/VCR cells. Moreover, microscopy demonstrated UCB induced apoptosis and necrosis in HL-60 parent cells in a dose and time dependent manner with apoptosis greatest at low UCB -longer exposure durations, and necrosis predominating at high UCB regardless of exposure duration. In contrast, HL-60/VCR cells demonstrated minimal UCB cytotoxicity under the same conditions. Conclusions: We conclude that UCB impairs cell viability and induces apoptosis and necrosis in HL-60 parent cells in a dose and time dependent fashion whereas HL-60/VCR cells are relatively protected against UCB cytotoxicity. These findings suggest that human Pgp affords cytoprotection against UCB. Moreover, under the current study conditions, this Pgp cyotprotective effect appears to exceed that afforded by MRP1.
Supported by Children's Hospital of Pittsburgh, NINDS 38993 and the Mario Lemieux Foundation.
EFFECT OF MORPHINE ON NEUROGENESIS IN THE DEVELOPING RAT HIPPOCAMPUS
C. Traudt, K. Czernick, R. Rao. Division of Neonatology, Department of Pediatrics, University of Minnesota, Minneapolis, MN. Background: Pain management is an important aspect of neonatal care. Chronic pain during a neonate's stay in the NICU has been shown to have long lasting changes in pain tolerance, spinal cord level sensitization and altered pain-related behavior in later childhood. Opioids, such as morphine, form the mainstay of pain management in the preterm newborn infants. The adverse effects of morphine on the developing brain given in the days shortly after birth are not known. In adult rats, recurrent administration of morphine decreases the neurogenesis in the hippocampus. In humans and rats, the rapid phase of hippocampal development spans both pre-and postnatal periods. Morphine administration during the neonatal period may adversely impact hippocampal neurogenesis and result in cognitive impairments. Objective: To evaluate the effect of recurrent morphine administration on neurogenesis in the granular cell layer of the dentate gyrus of the hippocampus in developing rats. Design/Methods: Sprague Dawley rat pups were administered morphine (10 mg/kg, intraperitoneal (i.p.) twice daily) from postnatal day (P) 3-7 (neurodevelopmentally equivalent to 24 -34 week human neonate). Littermate controls were given normal saline as a vehicle. Bromodeoxyuridine (BrdU) was injected (100 mg/kg, i.p.) on P7 to label newly dividing cells and brains were harvested on P8. The BrdU positive cells in the granule cell layer of the hippocampi of morphine group and control group were counted and compared in 20 M coronal brain sections using Image J program (N ϭ 12 brain sections from 2 rats/group). Results: Compared with the control group, the mean Ϯ SD BrdU positive cells in the dentate gyrus were 50% lower in the morphine treated group (control group 220 Ϯ 77 and morphine group 109 Ϯ 48, p ϭ 0.001). Conclusions: Recurrent morphine exposure during the postnatal period is associated with decreased neurogenesis in the dentate gyrus of the hippocampus in developing rats. Altered hippocampal development may lead to cognitive deficits in human preterm infants exposed to recurrent opioid administration.
GABAERGIC NEURONS IN THE NUCLEUS TRACTUS SOLITARIS ARE NOT INVOLVED IN THE LARYNGEAL CHEMOREFLEX
MM Mohamed, S Zaidi, J Abu-Shaweesh. Case Western Reserve University, Cleveland, OH.
Activation of laryngeal mucosa causes apnea in neonates and newborn animals. This reflex apnea is mediated through, and can be activated by electrical stimulation of, the superior laryngeal nerve (SLN). Blocking GABA A receptors was shown to prevent SLN stimulation induced apnea. It was suggested that second order neurons in the Nucleus Tractus Solitaris (NTS) activate GABAergic neurons within the NTS that inhibit inspiratory neurons and cause apnea during laryngeal stimulation. We aimed to identify if GABAergic neurons in the NTS are activated during SLN using c-Fos expression as non-specific marker of neuronal activation. Three week old rats pups, (n ϭ 10), were initially anesthetized using urethane then ventilated through a tracheostomy and vagotomized. In five electrical stimulation of the SLN was performed for 15 seconds every 4 minutes for 30 -60 minutes using currents that caused cessation of diaphragmatic activity. The other five rats underwent sham surgery without SLN stimulation. All animals were perfused using 4% paraformaldehyde 1-2 hours after the end of stimulation or comparable time in the control group. The brainstem was excised and immunohistochemistry double staining for parvalbumin, a marker for GABAergic neurons, and c-Fos protein were employed to identify GABAergic neurons activated during SLN stimulation in medullary slices. We observed that there was increased c-Fos expression within the NTS in the stimulated animals relative to the control. While we observed parvalbumin positive cells in the NTS, there was no co-localization of paravalbumin with c-Fos in any of these neurons. From these preliminary studies we conclude that SLN stimulation activate non-GABAergic neurons within the NTS. We further conclude that GABAergic inhibition of respiration during laryngeal stimulation is localized outside the NTS. We speculated that SLN stimulation activates neurons in the NTS that stimulate GABAergic interneurons in the ventrolateral medulla causing release of GABA at, and inhibition of, inspiratory neurons and subsequent apnea. Future experiments will try to identify the location of these activated GABAergic neurons. Background and Purpose of Study: Human skeletal disorders are prevalent in medicine yet the genetic and physiologic mechanisms that regulate skeletal growth, homeostasis, repair and regeneration are protean and poorly understood. For example, of the 372 skeletal dysplasias, a genetic etiology exists for only 140 of them. Zebrafish are well suited for investigating skeletal biology. They posses a classic vertebrate skeleton including endochondral and membranous elements, they have the three signature skeletal cell types (osteoblasts, osteoclasts and chondrocytes) and they are amenable to forward genetic studies. Therefore, zebrafish mutants that alter skeletal morphology and physiology may provide insight into the fundamentals of human skeletal biology. Methods and Summary of Results: An ENU-based forward mutagenesis screen identified the overgrowth mutant rapunzel (rpz). Adult rpz heterozygotes have defects in skeletogenesis, resulting in overgrowth of the axial and the appendicular skeleton. We mapped rpz to a 46 kb critical region on chromosome 16. This critical region contained four novel, paralogous genes. We then used a combination of genomic BAC sequencing in addition to 3' and 5' RACE to examine the coding sequences of the paralogs in the rpz critical region. One transcript, heretofore referred to as rpz, contained a missense mutation (T269A) that would result in a non-conserved amino acid substitution (V90E). Using the rpz homozygous embryonic phenotype as a surrogate, we show that knockdown of rpz completely rescues the homozygous embryonic phenotype, but has no effect on wild type or heterozygous rpz embryos, suggesting that rpz is a gain of function allele. In silico data suggest that rpz is a transmembrane protein, a model supported by preliminary experiments both in transfected mammalian cells and in zebrafish cell lines using an antibody generated against the endogenous rpz protein. Finally, we used blastula transplantation to explore the cell/tissue autonomy of the rpz mutation. Analysis of rpz chimeras suggests both cell autonomous and non-cell autonomous mechanisms for skeletal overgrowth in rpz mutants. Conclusions: Forward genetics identifies rpz, a skeletal overgrowth mutant caused by a gain of function lesion in the previously undescribed rpz gene. rpz encodes a novel, transmembrane protein. Progress in characterizing the rpz protein will be described.
A GAIN OF FUNCTION MUTATION CAUSING SKELETAL OVERGROWTH IN THE RAPUNZEL ZEBRAFISH MUTANT
EARLY TREATMENT OF IDA DOES NOT REMEDIATE BEHAVIORAL DEF-ICITS IN RATS
A Hurst, C Li, M Ricketts, F Shalabi, L Dreisbach, BT Felt. Center for Human Growth & Development, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI.
Background: Iron deficiency anemia (IDA) during development has been demonstrated to have long-lasting effects on cognition and behavior in humans. In rats, IDA during early development is associated with delayed motor development and poor performance in the spatial watermaze in adulthood despite treatment with iron after weaning (postnatal [P] day 21).
Objective: The purpose of this study is to assess whether earlier dietary intervention with iron for IDA prior to P8 (approximately equivalent to newborn age for human development) can correct short and long term changes in behavior and learning in the rat. Methods: Sprague Dawley rat mothers received iron sufficient (IS) or ID diets during gestation and early lactation. At P8, all pups were cross fostered onto IS mothers. All rats had testing for motor development at 3-day intervals (P9 -P21). Pup hematocrit was measured at P21 and in adulthood. All rats had 8, 1-minute swim trials in the Morris watermaze: 3 trial days at P25; 14 trial days at P90. Latency, speed, path length, and thigmotaxis (tendency to stay along the wall) were measured. A 1-minute probe trial was performed at the older age. Developmental and watermaze variables were compared by diet group using Student's T-test and repeated measures ANOVA with significance p Ͻ 0.05. Results: Hematocrit was reduced by 13% for ID pups (p Ͻ 0.001) as compared to IS at P21; by 3 months there was no significant difference by diet group. Developmental measures were significantly delayed for ID pups at P9 -15, but reached IS levels by P21. In the P25 watermaze, the IS pups swam significantly faster than the ID pups (p Ͻ 0.001). Controlling for swim speed, latency to platform was longer for ID pups (p Ͻ 0.02). In the platform quadrant, the path length was significantly less across days for ID pups (p Ͻ 0.02). ID pups had a higher thigmotaxis across days (p Ͻ 0.001) compared to IS pups. Assessing across all training days at 3 months of age, ID rats had a trend for higher thigmotaxis (p Ͻ .08) and a lower path length in the platform quadrant (p Ͻ 0.05). In the 1-minute probe trial, ID rats show a lower percent path in the platform quadrant (p Ͻ 0.05) and a trend for a higher thigmotaxis path (p Ͻ 0.07). Conclusion: Despite iron treatment for ID by early lactation, previously ID pups demonstrated lags in motor development and poorer watermaze performance at P25 and in adulthood. This study suggests that ID during gestation can have long-lasting behavioral effects that are not remediated by iron treatment.
BIOENGINEERING OF COAGULATION FACTOR VIII FOR EFFICIENT EX-PRESSION: ELIMINATION OF A DISULFIDE LOOP IMPROVES SECRE-TION
SR Selvaraj, SW Pipe. Department of Pediatrics, University of Michigan, Ann Arbor, MI.
Coagulation factor VIII (FVIII), a glycoprotein cofactor, performs a critical function in the intrinsic blood coagulation pathway and a quantitative or qualitative deficiency of this protein results in Hemophilia A. The primary obstacle to producing low cost replacement therapy is the inherent limitation of commercial recombinant FVIII (rFVIII) production since its expression is 2 to 3 orders of magnitude lower than that of other comparably sized proteins. Inefficient mRNA expression, protein misfolding & chaperone mediated retention and the requirement for facilitated transport from the Endoplasmic Reticulum (ER) to Golgi have been identified as the major bottlenecks to efficient expression of rFVIII. Bioengineering strategies aimed at clearing each of these hurdles have resulted in the generation of several rFVIII variants with more efficient expression rates. Elimination of specific disulfide loops has previously been shown to confer a secretion advantage in certain proteins. In this strategy, the effect of each of FVIII's eight disulfide bonds on FVIII secretion was determined. The disulfide bonds were eliminated by replacing the corresponding cysteine residues with glycine residues by a PCR-based site-directed mutagenesis protocol using mutagenic primers. The disulfide mutants were created both in the full length FVIII as well as a bioengineered rFVIII variant (226/N6) with enhanced (5-10-fold) secretion efficiency. All the mutants were characterized by restriction enzyme digestion and DNA sequencing. The secretion capabilities of all the mutants were studied by transient transfection in Chinese Hamster Ovary (CHO) and COS-1 cells. FVIII activity was measured by one-stage and two-stage clotting assays and the antigen levels were quantified by anti-FVIII light chain sandwich enzyme-linked immunosorbent assay (ELISA). Elimination of the disulfide loop between cysteine residues at positions 1899 and 1903 resulted in a 1.5-2-fold increase in secretion of both wild-type FVIII and even the 226/N6 variant as reflected in both the antigen levels and the activity of the protein. Disruption of each of the other seven disulfide bonds resulted in retention of the protein intracellularly indicating that these were indispensable for the correct folding and secretion of FVIII. Such combined targeted bioengineering strategies may facilitate more efficient production of rFVIII toward lower cost replacement therapy.
EFFECTS OF IRON DEFICIENCY AND ERYTHROPOIETIN ON TRANS-FERRIN RECEPTOR EXPRESSION IN NEWBORN RAT
C Pittner, SE Blohowiak, PJ Kling. University of Wisconsin Pediatrics, Madison, WI.
Background: The availability of iron is critical in cell proliferation necessary for infant growth. Duodenal intestinal epithelium absorbs milk-borne iron, delivering it to enterohepatic circulation. Once inside, the epithelial cell exports iron-transferrin complexes via the transferrin receptor (TfR) to be transported via the bloodstream to liver. Hepatic iron directly regulates intestinal iron absorption by negative feedback. Erythropoietin (Epo), found in human milk, stimulates erythropoiesis, but its role in iron absorption is unclear. Epo may upregulate TfR expression in some cell types. Purpose: Our aim was to understand whether Epo increases duodenal iron transport in iron-deficient anemic (IDA) newborn rats. First, we hypothesized that duodenal TfR expression would be higher in dam fed or IDA rats fed enteral Epo, compared to control. Methods: We studied newborn Sprague-Dawley rats from postnatal day 4 -12, damfed or iron-deficient artificial milk via gastrostomy (IDA). Enteral Epo was administered as 425 U/kg/d (Dam ϩ Epo, IDA ϩ Epo). H&E and Prussian blue iron analysis was performed on duodenum and liver. Immunohistochemistry for TfR was performed on duodenum, and color expression quantitated. Body or liver iron content was measured. Images were analyzed digitally by Spot and Metamorph Software. Results: Although body iron content was 30% lower in IDA group (p Ͻ 0.005), weights were similar. Duodenal weights were greater in IDA and IDA ϩ Epo than either Dam or Dam ϩ Epo (p Ͻ 0.05). Epo treatment did not alter weights. No Prussian blue staining of duodenum was observed, supporting no hemosiderin/storage iron buildup in enterocytes. TfR density was slightly higher in IDA, compared to DF (p ϭ 0.05), but was the same for the other groups. Liver iron content (g/g rat wt) was greater in IDA and IDA ϩ Epo than Dam or Dam ϩ Epo, p Ͻ 0.0005, but liver Prussian blue staining for hemosiderin was markedly lower in IDA and IDA ϩ Epo, compared to Dam or Dam ϩ Epo (p Ͻ 0.0001). Liver weights were greater in IDA and IDA ϩ Epo than either Dam or Dam ϩ Epo (p Ͻ 0.05). Epo did not alter liver weights. Conclusions: We observed greater TfR density with iron deficiency, but no appreciable effect with Epo. Because duodenal weights differed in iron sufficient vs. deficient rats, and Epo is known to increase villus surface area, we should examine TfR expression more quantitatively by immunoblot. Because Prussian blue hemosiderin does not account for the finding of greater liver iron in IDA, we will examine whether hemoglobin or ferritin iron is responsible for the greater total iron content.
ASSESSMENT OF AIRWAY GROWTH IN-VIVO USING HIGH RESOLUTION COMPUTED TOMOGRAPHY IN INFANTS AND TODDLER
L Rao, C. Tiller, J Balinotti, R. Kimmel, C. Coates, J. Cook, E. Hoffman, B. Katz, C. Denski, J. Nguyen, K. Applegate, R. Tepper. Riley Children's Hospital, Indianapolis, IN.
Background: Obstructive airways disease is a common respiratory problem early in life; however, our understanding of normal airway growth, as well as our ability to assess airway dimensions is relatively limited in this very young age group. High resolution computed tomography (HRCT) offers the potential to measure airway dimensions in vivo and assess airway growth early in life. Hypothesis: HRCT imaging can assess the growth of the conducting airways in infants and toddlers. Materials and Methods: Infants and toddlers scheduled to have a CT scan with sedation for non-respiratory problems were recruited. Infants were excluded for premature birth, cardio-respiratory anomalies or recurrent respiratory symptoms. Volumetric HRCT chest scans were obtained at an elevated lung volume (airway pressure of 20 cm H 2 O pressure). Lumen cross sectional area (CSA) was measured for the trachea and the first 4 generations (G1-4) into right (R) and left (L) lower lobes. Results: 15 subjects (6 males), mean age of 15.6 months (range: 3.9-32.3) were evaluated. Increasing lumen CSA correlated with increasing body length (Table) . CSA decreased from trachea to more peripheral generations (G1 to G4) and the larger airways had higher R 2 than the smaller airways. In addition, conducting airways in the R lung were larger than comparable generations in the L lung. Conclusions: HRCT can be used for in-vivo measurement of airway size in infants and toddlers and the conducting airways grow linearly with body size in this age range.
NIH grant HL054062.
THE SIMPSON GOLABI BEHMEL GENE, GLYPICAN-3, MODULATES COR-ONARY VASCULAR DEVELOPMENT, AND LOSS OF FUNCTION RESULTS IN CORONARY ARTERY FISTULAS
M Wong, A Ng, B Viviano, G Alba, C Pflederer, J Erlich, P Jay, S Saunders. Washington University School of Medicine and St. Louis Children's Hospital. Glypican-3 (Gpc3) is a heparan sulfate proteoglycan expressed widely on the surface of cells of mesodermal origin during vertebrate development. Loss of function mutations in the Gpc3 gene in humans results in Simpson Golabi Behmel Syndrome (SGBS), a rare and complex congenital overgrowth syndrome with a number of associated developmental abnormalities including congenital heart disease. We have evaluated mice bearing a loss of Gpc3 function and found that they display a similar phenotype to humans with SGBS, including a high incidence of congenital heart defects. Of 16 Gpc3-deficient animals examined at birth, we observed 4 VSDs, 3 coronary artery fistulas, 1 common AV canals, 1 double outlet right ventricle with VSD, and 1 PDA, while 14 wild-type littermate controls were all normal. The observance of coronary artery fistulas is especially noteworthy as this defect has not been previously reported in SGBS, and nothing is known about the molecular basis of this abnormality. Our more detailed analysis of Gpc3-deficient hearts reveals a delay in formation of the coronary vascular plexus, and consistent with GPC3 functioning as a co-receptor for fibroblast growth factor-9 (FGF9), we found a reduction in sonic hedgehog (Shh) mRNA expression and signaling, which is directly regulated by FGF9. Interestingly, we find that loss of Gpc3 function results in an asymmetric loss of SHH function with respect to formation of coronary arteries and veins, resulting in excess coronary artery formation to coronary veins. We hypothesize that his unbalanced development of coronary arteries leads directly to the formation of coronary artery fistulas. This work has broad significance not only to understanding the molecular basis of coronary artery formation, but potentially to our understanding of the molecular mechanisms relevant to revascularization following ischemic injury to the heart.
INCREASE OF B-TYPE NATRIURETIC PEPTIDE FROM BASELINE IN-CREASES THE RISK OF DEATH OR RE-TRANSPLANT IN PEDIATRIC CARDIAC TRANSPLANT PATIENTS
M Bramlet, R Moore, K Lane, D Murphy, R Caldwell, R Darragh, M Schamberger. Riley Hospital for Children, Indiana University, Indianapolis, IN.
The purpose of this study was to analyze longitudinal BNP data in pediatric cardiac transplant patients. Several studies have demonstrated the utility of BNP in the months following cardiac transplant. Our goal was to determine the utility of BNP in routine follow-up years after transplant and its relationship to the adverse event of death or re-transplant.
From October 2002 to July 2007, 53 pediatric cardiac transplant patients were treated in an unmatched case-control study. Along with routine studies, BNP values were drawn at regular intervals. 6 patients were excluded due to recent transplant, and 2 patients were excluded due to poor compliance. A baseline mean BNP was established for each subject utilizing all BNP values during year 2 post transplant, or the first year of measured BNP in those patients whose transplant preceded the study by more than 2 years. Another surrogate baseline value used was the median BNP of all data points since transplant. Univariate logistic regression was used to evaluate various BNP summaries and possible covariates on cardiac death.
There were 1260 BNP data points spanning 174 patient years. 10 (22.2%) of the 45 subjects experienced an event. Patients who eventually experienced an adverse event had a significantly higher baseline BNP (mean 397 Ϯ 292; median 407 Ϯ 347) when compared to patients without an event (mean 128 Ϯ 78; median 121 Ϯ 62; p ϭ 0.0170 and p ϭ 0.0284 respectively). Patients who received pulsed steroids within the last 210 days were more likely to experience an event than patients who did not (OR 16.36; 95% CI 1.64 -ϱ; p ϭ 0.0085). All subjects with adverse events attained a BNP value Ն250 during the 180 days preceding the event compared to only 37.1% of those who did not (OR: 21.19, 95% CI 3.04 -ϱ, p ϭ 0.0007). The log fold increase of the maximum BNP value in the last 180 days compared to the baseline median BNP is a risk for cardiac death (OR: 4.51, 95% CI: 1.15-17.67, p ϭ 0.0307).
Routine BNP measurements in the post-cardiac transplant pediatric patient allows for the determination of a median BNP which can be used as a baseline. Log fold increases from the median BNP as well as attaining a BNP value Ն 250 increase the risk of death or need for re-transplant.
EFFECT OF HEMODIALYSIS ON AORTIC STIFFNESS IN CHILDREN WITH END STAGE RENAL DISEASE
SR Patel, S Aggarwal, R Valentini, T L'Ecuyer. The Children's Hospital of Michigan, Detroit, MI.
Background: Children with end stage renal disease (ESRD) have significant cardiovascular morbidity and mortality, the pathogenesis of which may include altered aortic mechanics. Chronic volume overload may decrease the aortic distensibility (AD) and increase aortic stiffness(AS). We hypothesized that among children with ESRD, AD and AS would improve following HD. Methods: This was a prospective non-interventional study involving children (n ϭ 12) with ESRD, who underwent echocardiograms immediately before starting HD, mid-way during HD, and within 1 ⁄2 hour of completion of HD. Aortic systolic and diastolic diameters (SD and DD) were measured by 2D guided M-mode echocardiography. Systolic (SBP) and diastolic blood pressure (DBP) was measured and pulse pressure (PP) calculated. Measures of AD were derived as: Aortic strain (S) ϭ (SD-DD)/DD and AD ϭ 2 X strain X PP. AS was calculated as: Pressure strain elastic modulus (Ep) ϭ PP/S and Pressure strain normalized to DBP (Ep*) ϭ Ep/DBP. Results were expressed as mean Ϯ SD. Comparisons of measured variables were tested by ANOVA; statistical significance was assumed at p Ͻ 0.05. Results: The mean (ϮSD) fluid removed during HD was 1.7 Ϯ 1.15 L. The causes for ESRD varied. BP was not significantly different before, during or after HD. Both Aortic distensibility and Aortic Stiffness significantly worsened during hemodialysis and remained impaired at completion of HD. Change in AD and AS did not correlate with amount of volume removed, duration of HD, or duration of ESRD. Conclusion: Aortic distensibilty was impaired and the aortic stiffness increased significantly in children with ESRD following hemodialysis, irrespective of the underlying renal diagnosis and independent of a change in the blood pressure or volume removed. We speculate that the acute increase in aortic stiffness during hemodialysis may be secondary to endothelial dysfunction and may offset the cardiovascular benefits of volume unloading. Tokyo University of Pharmacy and Life Science, Tokyo, Japan. Purpose: To identify the phenotype of cell(s) involved in the coronary artery and aortic inflammation induced by Candida Albicans Water Soluble fraction (CAWS). In this model, a single immunization with CAWS causes coronary artery and aortic inflammation within three weeks. Methods: 6-12 week old C57Bl/6 (wt) mice were immunized once with CAWS intraperitoneally (I.P.) Mice were sacrificed on day 21-28 post immunization. Hearts were dissected and sectioned. Heart cells and splenocytes were analyzed by flow cytometry. Hearts were embedded in O.C.T. for H&E staining or for frozen sectioning. Summary: H&E staining showed that on average greater than 66% of immunized mice were affected. H&E showed aortic and coronary artery inflammation and appeared to contain neutrophils, macrophages and plasma cells. Subendothelial proliferation was prominent adjacent to the aorta. Coronary arteritis was frequently accompanied by obstruction of artery lumens. Disruption of the elastic lamina was observed in some but not all specimens. Affected mice exhibited splenomegaly consistent with immune activation. Flow cytometry showed increased numbers of splenocytes that expressed CD11b alone and the combination of CD11b and CD11c compared to mock immunized mice. Single color staining of cells isolated from cardiac lesions suggested the presence of cells that expressed CD3, CD11b and/or CD11c, and were virtually undetectable in non-immunized mice. Additional multicolor analyses of lesional cells including staining for MHC Class II are underway to further identify the CD11cϩ cells as DCs. Conclusion: CAWS immunization induces mouse coronary arteritis, aortitis, splenomegaly, and alters immune composition in the spleen. CD11bϩ cells have also been reported to be increased in another mouse model of aortitis in which infection with gamma herpes virus leads to a vasculitis phenotype, and in patients with vasculitis distinguished by auto-antibodies to anti-proteinase-3. CD11cϩ DCs have been reported in the coronary arteries of patients following KD. We hypothesize that in the CAWS model activated CD11bϩ macrophages and CD11cϩ DCs produce chemokines which then recruit T-cells and macrophages into the coronary arteries and aorta thus perpetuating an initial inflammatory trigger. Our results suggest that the CAWS model may mimic features of KD and human aortitis and thus may be useful in studying basic mechanisms of susceptibility and damage.
CD11B؉ AND CD11C؉ CELLS ARE INCREASED IN THE CAWS MOUSE MODEL OF KAWASAKI DISEASE (KD) SUGGESTING A ROLE FOR MAC-ROPHAGES AND DENDRITIC CELLS (DCS) IN THE PATHOGENESIS OF CORONARY ANGIITIS AND AORTITIS
PEDIATRIC DUODENAL CANCER AND BI-ALLELIC MISMATCH REPAIR GENE MUTATIONS
S Roy, L Raskin, VM Raymond, R Mody, SB Gruber. University of Michigan Health System, Ann Arbor, MI.
Gastrointestinal (GI) malignancies are extremely rare in the pediatric population, and have been observed to be associated with functional deficiencies of the mismatch repair (MMR) system causing a cancer-predisposition syndrome. We report the case of a 16-year-old female with personal history of duodenal adenocarcinoma and medulloblastoma and family history of T-cell leukemia in her brother at age 5. The purpose of this study is to describe the phenotype of bi-allelic MMR mutations and to underscore the features of pediatric duodenal carcinoma. Methods: Duodenal tumor tissue was analyzed for microsatellite instability (MSI) and protein expression. Blood samples of the proband and her parents were tested for mutations in the PMS2 gene. Current literature on pediatric duodenal adenocarcinoma and the phenotype of biallelic MMR mutation carriers are reviewed. Results: Duodenal carcinoma demonstrated high degree MSI and absence of PMS2 in tumor and normal tissue, with intact expression of MLH1, MSH2, and MSH6. Germline testing revealed a homozygous truncating mutation of the PMS2 mismatch repair gene (Q317X) in exon 9. The parents are first cousins, and each parent is heterozygous for PMS2 Q317X. A comprehensive literature review highlights that mismatch repairdeficiency syndrome (MMR-D) resulting from germline biallelic MMR inactivation significantly differs from heterozygous germline mutation in MMR gene that causes Hereditary non-polyposis colorectal cancer (HNPCC). Onset of tumors in MMR-D is as early as the first decade of life and most patients have café-au-lait macules. The tumor spectrum includes colorectal, brain, and hematological malignancies. Homozygous mutations in PMS2, MLH1 and MSH6 account for the majority of the MMR-D cases. Conclusions: It is important for pediatricians and pediatric oncologists to be aware of the possibility of occurrence of GI malignancies arising on the basis of defective mismatch repair in children and young adults with GI cancer. The pattern of a GI carcinoma presenting at a young age, with or without the presence of café-au-lait macules, should raise suspicion for MMR-D syndrome and should prompt referral to cancer genetics for evaluation. The absence of a significant family history of cancer does not diminish the likelihood of MMR-D syndrome, since this most typically presents as an autosomal recessive trait. Standard adjuvant chemotherapy regimens for adult GI cancer may not always be the best option for these patients, and insights from therapeutic studies of microsatellite instable cancers in adults may have implications for pediatric oncologic care. Purpose: Health outcomes for children with type 1 diabetes depend on maintaining a safe environment with close monitoring throughout the day, including at school. The Americans with Disabilities Act requires schools to accommodate the needs of children with diabetes. Furthermore, the American Diabetes Association (ADA) provides guidelines for school services for children with diabetes. Our objective was to determine families' perceptions of the degree to which their schools provide ADA-required services. Methods: A comprehensive structured questionnaire using Likert-type scales for measured variables was developed based on ADA recommendations. Families of school-aged children with type 1 diabetes presenting sequentially to diabetes clinic over five months were eligible (n ϭ 103). Questionnaires were completed at clinic and hemoglobin A1C (HbA1C) was obtained. Participation rate was 96% (n ϭ 99). Results: Eighty-four percent of respondents were nonhispanic Caucasian, similar to the demographics of type 1 diabetes; 57% of families had annual incomes over $50,000 and 63% had at least 1 parent with a college degree. Median child age was 12 years, and median duration of diabetes was 5 years. Eighty-four percent of children attended public and 16% private schools. Average HbA1C was 9.1% (range 6.2-15.1), higher among high school students than elementary students. Whereas the ADA recommends a written diabetes management plan be on record, only 64% of families reported that this occurs. Whereas the ADA recommends that two adults at school be able to check blood glucoses, administer insulin and glucagon for emergencies, 39% of families were unsure or believed these services were not provided. Whereas the ADA recommends that carbohydrate content of food offerings be available, only 19% of schools were reported to do so. Schools were rated higher in meeting ADA guidelines for allowing snacks, allowing needed bathroom breaks, and making accommodations for needed medical visits. Conclusions: Despite legal regulations and professional guidelines, parents report that schools do not consistently meet ADA guidelines for the safety and management of children with diabetes. Whether this reflects schools' non-adherence with recommendations or of families not being aware of schools' efforts, the data indicate substantial gaps in the family-school alliance that is essential for providing a safe and healthy environment for children with diabetes.
SCHOOL ADHERENCE WITH AMERICAN DIABETES ASSOCIATION GUIDE-LINES FOR CHILDREN WITH DIABETES: A STRUCTURED STUDY OF FAMILY PERSPECTIVES
TEMPORAL TRENDS IN PEDIATRIC INVASIVE PNEUMOCOCCAL DIS-EASE
DS Swanson, MA Jackson, CJ Harrison. Children's Mercy Hosp., UMKC Sch. of Med, Kansas City, MO.
Background: Pneumococcal conjugate vaccine (PCV-7) has been used in children since 2000 to prevent invasive disease. Methods: Data regarding invasive pneumococcal disease (IPD) at our institution from 1998 through 2000 and 2001 through 2007 were compared to assess the impact of PCV-7 on children in the Kansas City region. We collected selected demographic data, site of infection, and underlying medical conditions. All pneumococcal isolates had penicillin and cefotaxime susceptibilities obtained, and some isolates were serotyped. Results: In the last decade, we cared for 324 children with IPD. The total number of IPD initially decreased by 50% from pre-vaccine years, but has recently begun to rise. The relative number of cases of pneumococcal meningitis did not change, with an average of 6.7 cases/year for each study period. Since implementation of PCV-7, more cases of invasive infection occurred in older children (mean age 29 months through 2000 vs. 39 months after 2000, p ϭ 0.0097). Rates for penicillin resistance did not change, nor did the presence of underlying medical conditions. Since 2001, 70 of 74 (95%) isolates were nonvaccine-specific serotypes. Among the nonvaccine-specific serotypes seen, 49% are contained within the PCV-13 vaccine under development. Conclusion: The decline in the rate of invasive pediatric pneumococcal infections in the Kansas City region appears to have reversed, probably due to the emergence of non-vaccine serotypes. Penicillin non-susceptible invasive pneumococcal infections remain a concern. Practitioners need to stay vigilant when evaluating children with a nonspecific febrile illness. We performed a retrospective analysis of EKGs and echocardiograms (performed Ͻ 1 month apart) of children (1-18 yrs) with four chamber cardiac anatomy presenting to our clinic/echocardiography lab. Patients with open heart surgery, arrhythmias and bundle branch blocks were excluded. EKGs were examined for QRS duration (QRSd, ms), average time to maximal QRS deflection (TMD, ms), average 12-lead QRS voltage (12QRSV, mV), average product of 12QRSVand QRSd (12QRSVd, mV ms), R wave in V6 (RV6), S wave in V1(SV1), Sokolow-Lyon voltage (SLV, mV; S in V1/V2 ϩ R in V5/V6), Cornell voltage (CV, mV; R in aVL ϩ S in V3), SLV duration product (SLVd), CV duration product (CVd) and left ventricular mass (LVM) from EKG (LVMekg). LVH was defined as LVM index Ͼ 39.2 g /height 2.7 for males and 38.2 g/height 2.7 for females as derived from M-mode echocardiography by ASE formula. Sensitivity and specificity of each EKG criteria in detecting LVH was calculated. Results: Out of 179 children 66 children had LVH by echocardiography and 113 had no LVH. Conclusion: Standard EKG voltage criteria particularly RV6 is a poor indicator of LVH. LVM calculated by EKG is the most sensitive screening parameter for LVH in both age groups. We therefore propose that LVM calculated by EKG should be used to screen LVH in children and should be incorporated in current EKG machine software. Purpose: Children are at high risk for mosquito-borne disease exposure because they spend large amounts of time outdoors and often do not wear protective clothing or mosquito repellent. Our objective was to assess whether a school-based educational intervention focused on mosquito bite prevention and mosquito-borne disease, particularly West Nile virus (WNV), was able to: 1) improve WNV-related knowledge, 2) change WNV-related attitudes, 3) maintain these improvements, and 4) promote personal protective behaviors (PPBs) among participants and their families. Methods: Multisite, group-randomized, controlled trial. Students were randomized by classroom to either Neato Mosquito (NM) or Tar Wars (TW). Pre-and post-intervention knowledge, attitudes, and practices (KAP) surveys were compared to assess immediate KAP changes. Follow-up surveys, administered after the summer break 5-6 months later, assessed long-term KAP changes. Results: 345 students participated: 181 NM and 164 TW. 294 (85%) students completed follow-up testing: 152 NM and 142 TW. Age, gender, and baseline knowledge scores were equivalent between arms. Immediate post-test knowledge scores increased significantly, and remained significantly higher at follow-up in NM vs. TW. Post-intervention attitude scores showed increased fear of WNV, but this fear was not retained at follow-up. The NM arm reported more PPB use than those in the TW arm; they were 5 times more likely to dump out standing water and 3 times more likely to wear pants or long sleeves. The NM arm also reported more PPB use among their family members than those in the TW arm. Conclusions: Immediate and long-term improvements in WNV-related knowledge resulted from our intervention. Importantly, significant increases in PPBs were reported among NM participants and their families. Simple school-based educational interventions can play a significant role in promoting mosquito-bite prevention and can serve as an effective tool to communicate public health information to children.
SENSITIVITY OF ELECTROCARDIOGRAPHIC CRITERIA FOR SCREEN-ING LEFT VENTRICULAR HYPERTROPHY IN CHILDREN
POSTURAL TACHYCARDIA SYNDROME (POTS) AND FUNCTIONAL GAS-TROINTESTINAL DISORDERS (FGID): A ROLE FOR ALTERED ELECTRI-CAL ACTIVITY OF THE STOMACH?
S Safder, T Chelimsky, B Braunstein, E Heller, M ORiordan, G Chelimsky. Case Medical Center, Cleveland, OH.
Background: The cause of abdominal pain in patients with orthostatic intolerance is unclear. Children can be divided in sub-groups based on whether upright tilting replicates symptoms. We investigated whether the electrical activity of the stomach also changes with tilt position. Hypothesis: Children with FGID and POTS have changes in the electrical activity of the stomach during the upright portion of the tilt. Methods: All children undergoing autonomic testing were enrolled in this IRB approved prospective study. EGG was recorded 10 minutes in supine position and during the upright portion of tilt. EGG findings were correlated with autonomic diagnosis using Wilcox Rank Sum test. For the purpose of statistical analysis children were divided into two groups: 1) POTS and or vasodepressor syncope (VDS) 2) Non-POTS group include normal subjects and subjects with autonomic neuropathy. Results: 30 patients participated (20 females). Mean age 14 ϩ 3.5 years. 20 had POTS/VDS, 5 autonomic neuropathy, 5 were normal. 11 subjects with POTS replicated symptoms during upright portion of the tilt. When evaluating Channel 1 of EGG, subjects with POTS/VDS, but not those without POTS, showed a tendency for an increase in % arrhythmia (p ϭ 0.02) and a decrease in % normal gastric activity (p ϭ 0.02) in the upright position in relation to the supine position. Conclusion: This exploratory study suggests that the electrical activity of the stomach changes during the upright position in children with POTS/VDS, but not in children without this diagnosis. These changes could reflect abnormal autonomic control of gastric electrical activity and bear some relationship to the chief complaint of pain which worsens in the upright position. Further studies are needed to corroborate these findings.
Legend to Figures Changes in % normal gastric electrical activity lying vs standing. (Stars:POTS subjects; dots: non-POTS subjects) p ϭ 0.02. Background: ELBW infants are at risk for ROP and BPD. Supplemental oxygen (O2) may contribute to ROP and BPD. The optimal O 2 saturation (SpO2) ranges in ELBW infants have yet to be determined. Hypothesis: SpO2 target range of 85-92% vs. 86 -95% in ELBW who require oxygen will reduce the incidence of ROP and BPD without increasing mortality. Objectives: Compare the incidence of ROP and BPD in ELBW infants managed with SpO2 ranges of 85-92% and 86 -95%. Design/Method: Historical control observational quality improvement project involving ELBW infants (less or equal to 1250 grams) before and after changing SpO2 target alarm limits from 86 -95% to 85-92%. The incidence of severe ROP, moderate to severe BPD, NEC, IVH, PDA, survival, length of hospital stay, oxygen days, and ventilator days were collected. Results: Data were analyzed for 77 eligible infants who survived to discharge before and 55 eligible infants after a change in SpO2 alarm limits. Incidence of severe ROP (stage 3 or 4 or plus disease) decreased from 21% to 6% (P ϭ 0.0003) and ROP requiring laser surgery decreased from 16% to 4% ( P ϭ 0.00002). The incidence of BPD decreased from 68% to 42% ( P ϭ 0.01) in all eligible ELBW infants and the incidence of severe BPD decreased from 79% to 41% (P ϭ 0.0005) in eligible infants with birth weights less than 750 grams. No significant differences in the incidence of the other acute complications of prematurity evaluated. Conclusions: SpO2 limits 85-92% vs 86 -95% in ELBW infants supplemented with O2 reduces the incidence of ROP and BPD without an increase in mortality. 1,2 Most sick children present to community hospitals where expertise and equipment to place central venous catheters (CVC's) to obtain ScvO 2 measurements may not be readily available. PALS recommends using capillary refill time (CRT) for shock assessment in children because it is non-invasive and easy to perform. The relationship between CRT and ScvO 2 has not been determined. Objectives: To test the hypothesis that prolonged CRT (CRT 2 seconds) is associated with ScvO 2 70%. Methods: Prospective cohort study at a 16-bed tertiary-care PICU. Any critically ill child with a CVC was eligible for study. Patients with hypoxia (arterial saturation 96%) were excluded. Whenever ScvO 2 was obtained, concomitant central (chest or forehead) and peripheral (finger or toe) CRT's were measured using a stopwatch. Results: 39 paired CRT-ScvO 2 data from 17 patients were recorded. ROC curve analyses revealed that CRT's ability to discriminate ScvO 2 70% was good peripherally and excellent centrally (Figure) . Optimal discrimination was found at CRT 2 seconds for both (• central [sensitivity 0.75 The detection of most intraventricular hemorrhage (IVH) in very low birth weight (VLBW) infants was timed to the first three days of life in reports from the 1980s. More current practices including the prenatal administration of steroids and the postnatal use of surfactant are among practices that could alter the timing of IVH. The purpose of this study is to determine the likelihood of detecting IVH in VLBW infants after the first three days of life. Methods: Retrospective review of VLBW infants (birth weight Ͻ1500 grams) with IVH grades II-IV born between January 2001 and December 2007 cared for in a subspecialty perinatal center. Cranial ultrasonography was performed routinely on days of life (DOL) 1-3, 7-10, and 30 or if otherwise clinically indicated. We considered detection of IVH by ultrasound within the first 3 days as early and after three days as late. We excluded infants with incomplete records or those with ultrasound timing that did not allow proper classification into early or late IVH. Results: We evaluated data of 152 infants and included 88 infants with grades II-IV in the analysis. Late IVH was common and occurred in 32 (34%) while early IVH occurred in 56 (64%). Birth weight (mean, SD; 896 Ϯ 232 g vs 890 Ϯ 256 g), gestational age (mean, SD; 26.2 Ϯ 1.6 weeks vs 26.0 Ϯ 1.9 weeks), birth outside a subspecialty center (31.2% vs 41.1%), male gender (43.8% vs 48.2%), treatment with surfactant (96.9% vs 96.4%), severe IVH (56% vs 57%) and death prior to discharge to home (37.5% vs 35.7%) were not statistically different between infants who had late versus early IVH. However, mothers of infants with late IVH were more frequently treated with steroids (78% vs 55%, p ϭ 0.04). Within the group of infants who had late IVH, 12 (37.5%) had their IVH detected on or after DOL 10. Conclusions: Intraventricular hemorrhage was frequently detected in VLBW infants after the first three days of life. Prenatal treatment with steroids was associated with late IVH. We speculate that there is a change in the timing of IVH in VLBW infants associated with changes in perinatal practices introduced over the last few decades. Overall, this change is important when considering the timing of routine screening for IVH and when providing counseling to families.
OXYGEN SATURATION RANGES AND INCIDENCE OF RETINOPATHY OF PREMATURITY (ROP) AND BRONCHO-PULMONARY DYSPLASIA (BPD) IN EXTREMELY LOW BIRTHWEIGHT INFANTS (ELBW)
L
PROLONGED CAPILLARY REFILL TIME IS ASSOCIATED WITH CEN-TRAL VENOUS SATURATIONS > 70%
NOT HOOKED ON THE CLASSICS: AWARENESS OF KEY CASES IN NEO-NATAL ETHICS
JM Fanaroff. Pediatrics, Rainbow Babies & Children's Hospital, Cleveland, OH.
Background: The implementation of the Born-Alive Infants Protection Act (BAIPA) in 2002 has made infant resuscitation a prominent issue. A handful of legal cases are fundamental to understanding important neonatal ethical considerations. This study aimed to determine the knowledge base regarding some cases considered "classic" by the legal/ethical community. Methods: Two lectures on legal/ ethical issues at the Neonatology 2008 conference (Atlanta). Audience composed of 152 NICU RNs, NNPs, and neonatologists. Anonymous audience-response system polled awareness and opinions. Results: Baby Doe -1982 -infant with Down's Syndrome and TEF allowed to die without surgery. Most were aware (69%) of the case and disagreed (69%) with the court.
Baby K -1994 -court required a hospital to provide ventilation to an anencephalic infant. Most were unaware (63%) of the case and disagreed (73%) with the court.
Miller (Jury) -1998 -Hospital sued for resuscitating a 23-week infant without consent and against parental request. Family awarded $65 million (later overturned). Most were unaware (62%) of the case and agreed (87%) with the jury.
Montalvo -2002 -Hospital sued for resuscitating a 23-week infant without consent. The court found that the Baby Doe regulations prohibited the parents from withholding treatment because the child was not dying or comatose. Most were unaware (82%)of the case and disagreed (63%)with the court.
Sun Hudson -2005 -Court allowed hospital to withdraw support on an infant with thanotophoric dysplasia over the objections of his mother. Most were unaware (84%) of the case & all agreed (100%)w/ the court.
Conclusion: Certain legal cases can fundamentally impact care in the NICU. This study is the first to look at awareness of these decisions in a group of NICU providers.
1. There are a large number of providers who are unaware of important legal cases. 2. There is generally no moral concensus among providers on the appropriateness of neonatal care for extremely ill newborns.
3. Efforts should be directed to educating providers on the "classic" cases in neonatal ethics.
EFFECT OF INTERMITTENT HYPERCAPNIA ON RESPIRATORY CON-TROL IN RAT PUPS
J Steggerda, CA Mayer, R Martin, CG Wilson. Department of Pediatrics, Case Western Reserve University, Cleveland, OH. Preterm infants are subject to fluctuations in blood gas status associated with immature respiratory control. Intermittent hypoxia during early postnatal life has been shown to increase chemoreceptor sensitivity and destabilize breathing pattern, however intermittent hypercapnia remains poorly studied. Therefore, to test the hypothesis that intermittent hypercapnia results in altered respiratory control, we examined the effects of daily exposure to intermittent hypercapnia on the ventilatory response to subsequent hypercapnic and hypoxic exposure in neonatal rat pups. Exposure cycles consisted of five minutes of intermittent hypercapnia (5% CO 2 , 21% O 2 , balance N 2 ) followed by ten minutes of normoxia. Rat pups were exposed to 18 exposure cycles each day for one week, from postnatal day 7 to 14. We analyzed EMG recordings of diaphragm from pups exposed to subsequent acute hypercapnic (5% CO 2 ) and hypoxic (12% O 2 ) challenges. In response to a subsequent hypercapnia challenge there was no significant difference in the ventilatory response between control and intermittent hypercapnia-exposed groups. In contrast, intermittent hypercapnia-exposed rat pups showed an enhanced ventilatory response to hypoxic challenge with an increase in minute EMG to 118 Ϯ 14% of baseline versus 107 Ϯ 13% for control pups (p Ͻ 0.05). We speculate that prior hypercapnic exposure may increase peripheral chemoreceptor response to subsequent hypoxic exposures and result in perturbed neonatal respiratory control. Background: It is known that increased maternal birthweight (MBW) is associated with increased gestational age in singleton births. Similarly, studies have demonstrated a positive association between MBW and infant birthweight (BW). One relatively small cohort study (N ϭ 131) by Morley et al (2007) recently reported that MBW has an even stronger effect in twin pregnancies. Objective: To confirm the positive correlation of MBW with infant gestational age and BW in a large, multiethnic, geographically defined population. Method: We selected the birth records of 3196 mothers born in 1956-76, matched with the birth records of their twin infants delivered in 1989-91, from the Illinois Transgenerational Birth File (TGBF). We then analyzed the relationship of MBW to gestational age and combined BW of each twin pair. The effect of MBW was then determined separately for African American (AA) and White sub-populations. Results: The positive effect of MBW on gestational age and twin pair combined BW was confirmed in the large birth population from Illinois. The gestational age increased by 0.65 weeks (95% CI 0.41-0.89) per kg increase in MBW. There is a rise of 452 g (95% CI 376-528) in twin pair combined BW per kg increase in MBW. The relatively narrow confidence intervals derived from our population included the point estimates reported by the previous, much smaller study. Similar effects were demonstrated among African Americans and Whites, but the effect was stronger in African Americans, for whom the gestational age increase per kg MBW was 0.78 weeks, (CI 0.24-1.32), compared with 0.36 weeks (CI 0.1-0.63) in Whites. The twin pair BW increase per kg MBW was 415g (CI 269-561) for AA and 320g (CI 228-412) for Whites. This MBW effect on twin combined BW is larger than the MBW effect on singleton BW of approximately 250g per kg MBW increase, as previously reported for the Illinois TGBF by Coutinho et al (1997) . Conclusions: Our finding that maternal birthweight has a positive impact on twin gestational length and twin total birthweight confirms the only previous study of this phenomenon, performed on a small clinical sample in Australia. Our study also extends the previous work by demonstrating variations by maternal race. The implication is that prevention of prematurity should start at least one generation prior, especially in African Americans twin pregnancies.
MATERNAL BIRTHWEIGHT: IMPACT ON TWIN PREGNANCY OUTCOME
IN-HOSPITAL GROWTH IN VLBW INFANTS FED MATERNAL MILK, DO-NOR MILK, AND PRETERM FORMULA
TT Colaizy Susan Carlson, Ekhard Ziegler. University of Iowa, Iowa City, IA.
Background: Human milk diets may result in poor growth in VLBW infants compared to preterm formula. Objective: To compare in-hospital growth of VLBW infants fed maternal milk, donor milk, and preterm formula. Design/Methods: Retrospective cohort study of VLBW infants born between 1/1/2003 and 6/1/2005. Full enteral intake data was collected. Neonatal parameters and in-hospital growth were compared across three diet groups: full maternal milk, full donor milk, and full formula. SAS 9.1.3 was used for analyses. Results: Data is available for 150 of 180 infants. 68 met criteria for inclusion: 29 maternal milk, 16 donor milk, and 23 formula. Formula infants were born at later gestational ages (EGA) than milk fed (29.1 vs. 26 weeks, p Ͻ 0.001). EGA adjusted lengths of stay were similar among groups (p 0.19). Maternal and donor milk infants had similar discharge weights, (3240 g vs. 3147 g, p 0.87), and were discharged at similar EGA (40.5 weeks vs. 40.3 weeks, p 0.82). Formula infants were heavier for EGA at discharge (p 0.03), but had similar EGA at discharge adjusted for birth EGA (p 0.17). Weight gain for four time periods, 0 -14 days of age, 16 -35 days, 36 -56 days, and 57 days-term did not differ between groups ( p 0.25, p 0.41, p 0.91, p 0.05). Conclusions: In our population, VLBW infants fed human milk do not grow more slowly than those fed formula. Maternal and donor milk diets result in similar growth.
MEDICAL HOME FOR NICU DISCHARGES AS TRANSITIONAL PRIMARY CARE-ELEVEN YEAR FOLLOW-UP
G Srinivasan, A Harrison, B Shryock-Kastak, M Del Pino. Sinai Children's Hospital Chicago, IL.
Background: Care after discharge from NICU is a complex task in inner city hospitals due to target populations 1) lack of insurance, 2) language barriers, 3) limited parental understanding of the child's problems, 4) lack of family resources including transportation, and 5) literacy. Objective: 1) To establish developmentally-oriented, family-centered primary care model within developmental sub specialist practice for all discharges from neonatal intensive care unit (NICU); 2) to address medical needs and provide care coordination for patients and families; 3) to facilitate transition of care to community providers; and 4) follow-up of patients with abnormal results of neonatal screen Design/ Methods: First visit is provided irrespective of ability to pay or HMO authorization status. The neonatal course is reviewed with the family to improve their understanding of the child's condition. The clinic social worker addresses the infant's care and mother's needs, and provides care coordination and access to governmental benefits. The child's "risk" status is graded into three levels based on medical assessment and social worker's assessment of environmental risk factors. Level-1 patients are provided with the opportunity to transition to community providers after initiation visit; Level-2 infants (uncomplicated low birth weight infants) are cared for up to one year of age or longer based on parental preference; Level-3 infants with disabilities and complex medical needs area not discharged from the clinic. Results: A total of 400 new babies per year have been seen in the clinic for the past eleven years. Annual rate of transition to community care is 48%, 65% and 72% by age one, two and three respectively; attrition was minimal after four years of age-due to need of medial help or family's desire to return for care. The number of neonates lost for follow up decreased from 50% to 10% in the last year due to addition of the nurse practitioner who co-ordinates care with primary care physicians. Conclusions: This model of outpatient care for high-risk neonates by single provider team of social worker and nurse practitioner facilitates the successful and safe transition of patients from intensive care unit to health maintenance without interruption in continuity of care. Social worker is essential in ensuring continuity of care and family needs. Leaving it to the parent to decide when to transition out is not detrimental to clinic goal of seeing mostly neonates in their first year. Tracking all neonatal and hearing screens by a single provider improves compliance with follow up.
CHARACTERIZATION OF VISUAL FUNCTIONAL RESPONSE IN NEW-BORN INFANTS USING HIGH DENSITY NEAR INFRARED SPECTROS-COPY
SM Liao, NM Gregg, BR White, TE Inder, JP Culver. Washington University School of Medicine, Saint Louis, Missouri.
The neurodevelopmental outcome of NICU infants remains a major clinical concern with a significant portion of infants suffering from CNS injuries, leading to cognitive and behavioral deficits in childhood. Functional neuroimaging therefore may provide early recognition of neural deficits in high risk infants and ultimately improve outcome. Near infrared spectroscopy (NIRS) is a valuable functional neuroimaging technique that can provide a more complete picture of cerebral hemodynamics (i.e. cerebral blood flow, oxyhemoglobin, deoxyhemoglobin, and total hemoglobin) in real-time in the newborn population at the bedside. Previous functional NIRS studies involving infants have shown varying results in visual response patterns and differ from the more established adult pattern. Potential confounds include the subjects' behavioral state, age, and the behavioral protocol, as well as measurement artifacts suffered by most NIRS systems. In this study, we recruited infants within the first three days of life and studied them in the sleep state using a novel high-density NIRS system that has previously been demonstrated to have high performance in adults (Zeff B, PNAS 2007). In 8 out of 9 infants, we found increases in both oxyhemoglobin and total hemoglobin with a decrease in deoxyhemoglobin, similar to the adult pattern (Figure 1 A-C) . Furthermore, this functional response appears to be localized and specific to the visual cortex. Our data suggest that the neurovascular coupling in the visual cortex may be mature at term. In the future, similar studies involving older cohorts and preterm infants (using our simple and reliable visual stimulation protocol with our high-density NIRS system) may help to further understand the vulnerable infant brain. Overall, this study will provide a strong foundation for the development of NIRS as a tool for clinical utility. 
LYMPHANGIOGENESIS IN THE EMBRYONIC HEART
G Karunamuni, K Yang, YQ Doughman, J Wikenheiser, P Parsons-Wingerter, M Watanabe. Rainbow Babies and Children's Hospital, John Glenn NASA Research Center, Cleveland, OH.
The lymphatic network is essential for maintaining homeostasis within the internal environment, and the lymphatics of several adult organ systems, including the heart, have been described. However, the lymphatic vasculature of the developing heart has not been investigated in detail. There is clinical relevance to studying the cellular and molecular mechanisms of lymphatic vessel growth in the heart in order to treat or reduce edema due to congestive heart failure. This understanding may also be applicable to alleviating edema in other settings where it would be beneficial to initiate or enhance lymphangiogenesis. The transcription factor Prox-1 has frequently been used to label the lymphatics, and it is widely believed that Prox-1-positive lymphatic precursor cells have a venous origin. However, we propose that those of the embryonic heart may also arise from the proepicardial organ, which gives rise to the embryonic epicardium and cells comprising the coronary vessels. In our study, quail embryonic hearts were analyzed for Prox-1 immunofluorescence at developmental stages when vasculogenesis is active in the epicardium. For comparison, embryonic mouse hearts were also analyzed for expression of Prox-1 as well as two other lymphatic markers, lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) and vascular endothelial growth factor receptor 3 (VEGFR-3). In the whole quail hearts, Prox-1 identified a widespread, branching network of lymphatic vessels that first appeared on the aorta and pulmonary trunk at HH Stage 26 (Embryonic Day 5) and then continued to extend over the base of the great vessels and a large portion of the ventricles. However, even at HH Stage 24 (Embryonic Day 4), Prox-1 was already present in atrial and ventricular cardiac myocytes, in the lining and mesenchyme of the endocardial cushions, and a few epicardial cells. Thus, Prox-1 may function in regulating valve development and cardiac myocyte differentiation, as well as lymphangiogenesis. In the mouse embryonic heart, Prox-1 staining was not colocalized with expression for Lyve-1, which was expressed in individual epicardial cells and vessels in the myocardium, until after Embryonic Day (ED) 13.5. Furthermore, all three lymphatic markers were found in an adult rat epicardial cell line (ARECs) and an embryonic mouse epicardial cell line (EMECs), both of which also expressed a different form of Prox-1 in Western Blots compared to whole heart tissue samples composed primarily of cardiac myocytes. Our results suggest that the precursors of the cardiac lymphatics may migrate into the embryonic heart via the great vessels or originate from the epicardium.
THE EFFECTS OF BENZYL ALCOHOL AND PROPYLENE GLYCOL ON L1 MEDIATED ACTIVATION OF ERK1/2
TT Lai, N. Tang, M. He, C.F. Bearer. Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University.
Intro/Background: Inactive ingredients in medications act as preservatives, preventing microbial growth, and stabilizing medications as liquids or creams. Typically these chemicals are used in small concentrations and their effects on patients are minimal if at all. Benzyl alcohol and propylene glycol are two chemicals that have had adverse effects in neonates including death, developmental delay, cerebral palsy, central nervous system depression, lactic acidosis, and seizures. Exposing premature neonates to these inactive ingredients could specifically affect their central nervous system growth and development. Objective: L1 is a transmembrane glycoprotein which promotes neurite outgrowth via an endocytic recylcing pathway. ERK is a protein which is activated/phosphorylated through this pathway by L1. We hypothesize that by exposing neurons to benzyl alcohol and propylene glycol, activation of ERK decreases and subsequently L1 mediated neuronal growth will be affected. Design/ Methods: We took cerebellar granule neurons from postnatal day 6 rat pups and plated them overnight on poly-L-lysine with DMEM/10% FBS on tissue culture plates. We then serum starved the cells for three hours prior to triggering. Benzyl alcohol, propylene glycol, and ethanol were added 1 hour prior to triggering. Ethanol was used as a negative control because it has already been shown to decrease activation of L1 and ERK. The amounts of benzyl alcohol and propylene glycol were equivalent to the maximal serum concentrations seen with neonatal toxicity, 28.7 meq/L benzyl alcohol and 900 mg/dL propylene glycol. We triggered the cells by adding clustered antibody to L1. We then put the cells on ice after 10 minutes and scraped and lysed the cells. Cell lysates were then dierctly Western Blotted after determining protein concentrations. Results: Benzyl alcohol and propylene glycol significantly inhibited activation of ERK. The relative densities of the protein bands compared to those not exposed to the chemicals were 34% and 62% respectively with a p value Ͻ 0.05. Conclusion: Benzyl alcohol and propylene glycol inhibit activation of ERK in a manner similar to ethanol and subsequently are likely to affect L1 mediated neurite outgrowth. It is still unclear, however, from just these experiments where in the endocytic recylcing pathway benzyl alcohol and propylene glycol act.
ETHANOL'S REDISTRIBUTION OF L1 CELL ADHESION MOLECULES IN LIPID RAFTS UNDERLIES ITS EFFECTS ON L1 MEDIATED NEURITE OUTGROWTH AND L1-L1 CELL ADHESION
N Tang, M He, S Fox, B Farah, C F Bearer. Rainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, OH.
Introduction: Alcohol drinking during pregnancy is the cause of fetal alcohol syndrome (FAS). L1 cell adhesion molecule (L1) is implicated as a target for ethanol toxicity due to the similarities in neuropathologies of patients with FAS and those with L1 mutations. Previous studies have shown that ethanol inhibits L1-L1 cell adhesion. We have previously shown that pharmacologic levels of ethanol both inhibit L1 mediated neurite outgrowth, and increase the proportion of L1 present in lipid rafts. Purpose: The purpose of this study is to determine if the same mechanism underlies ethanol's redistribution of L1 in lipid rafts and inhibition of L1-L1 cell adhesion. If the mechanism is the same, then L1 redistribution should have the same dose response curve and cutoff point of alcohol chain length as those published for inhibition of L1 homophilic binding. Method: Cerebellar granule neurons from postnatal day 6 rat pups were cultured on poly L-lysine for 40 h. Alcohols were added 1 hour prior to harvest. The cells were harvested and pooled into lipid raft (LR) and non-lipid raft (N) fractions. Results: The dose response curve should an IC50 of 3-5 mM ethanol, similar to the IC50 for ethanol inhibition of L1-mediated neurite outgrowth (Bearer et al 1999) and L1-L1 cell adhesion (Ramanathan et al 1996) . Ethanol (25 mM) and butanol (2 mM) caused redistribution of L1 within lipid rafts, but pentanol (5 mM) did not, the same chain length cutoff as reported for L1-L1 cell adhesion (Ramanathan et al 1996) . Conclusions: We conclude that the same mechanism underlies the ethanol evoked redistribution of L1 in lipid rafts as that of ethanol's inhibition of L1-L1 cell adhesion. We further conclude that the interaction of L1 with lipid rafts may be the site of ethanol's toxicity.
CD47 EXPRESSION IS DIMINISHED IN NEONATAL NEUTROPHILS
DW Lawrence, JM Koenig. Department of Pediatrics, Saint Louis University, St. Louis, MO.
Circulating polymorphonuclear neutrophils (PMN) are short-lived cells and undergo programmed cell death, or apoptosis, within 24 -48 hours following release from the bone marrow. Using flow cytometry we observed that neonatal neutrophils express less surface CD47 than adult neutrophils. In both cell types, induction of spontaneous apoptosis by culturing for 24 hours led to a decrease in surface expression as well as total cellular expression of CD47. To assess CD47 surface expression in surviving versus apoptotic PMN populations, cells were co-stained with CD47 and annexin-V-PE. We observed greater CD47 expression in surviving compared with apoptotic adult PMN. In contrast, CD47 surface levels in apoptotic and surviving cord blood PMN were similar. Current research demonstrates that decreased CD47 surface expression triggers phagocytic uptake by macrophages via interactions with SIRP-alpha on the macrophage. In the absence of differential CD47 expression on the target cells, resident macrophages may not be able to differentiate between apoptotic and non-apoptotic populations. Thus, the observed similarity in CD47 surface expression in apoptotic and non-apoptotic cord blood neutrophils may lead to their prolonged existence at sites of inflammation.
GHRELIN LEVELS IN CORD BLOOD FROM CONCORDANT AND DISCOR-DANT TWIN PAIRS: ASSOCIATION WITH BIRTH WEIGHT AND POST-NATAL CATCH UP GROWTH
U Sharih, B Parilla, B Puppala, R Donovan. Advocate Lutheran General Children's Hospital. Park Ridge, IL.
Ghrelin is a 28 amino acid n-octonylated peptide, which has growth hormone releasing activity, and has been isolated from human gastric endocrine cells, pituitary, hypothalamus, placenta and gastroenteropancratic tumors. Ghrelin is actively synthesized by the placenta and has been detected in cord blood at 30wks gestational age indicating it may play a role in fetal growth and development. Previous research has found cord blood ghrelin concentrations of small for gestational age (SGA) infants to be greater than those of appropriate for gestational age (AGA) infants. SGA twins with high ghrelin concentrations may have a better chance for catch up growth after one year. In addition, differences in cord blood ghrelin levels within discordant twin pairs may correlate more strongly with catch up growth in the smaller twin. This is a prospective, observational study. After obtaining parental consent, a 1mL venous cord blood sample was taken from 20 twin pairs; 13 concordant, 7 discordant. Blood samples were centrifuged and serum was immediately frozen. Plasma samples were sent to Millipore research lab for Ghrelin analysis. Ghrelin levels were then compared to infant size and growth progress at 2-months, 4-months and 6-months of age. Growth data is currently available for 20 infants up to 2 months of age. A negative correlation was observed in discordant twins between cord blood ghrelin levels and birth growth parameters, however none were significant. There appears to be a negative correlation between cord blood ghrelin levels and 2-month post-natal weight gain among all infants. However, this is not statistically significant. Lack of statistical significance may be a reflection of limited sample size as well as short-term follow-up data. Data collection and enrollment continues with goal sample size of 50 twin pairs upon study completion.
HEMOLYTIC UREMIC SYNDROME-INCIDENCE AND ETIOLOGIES AT A REGIONAL CHILDREN'S HOSPITAL 2001-2006
R J Pomajzl, M Varman, A Holst, A Chen. Children's Hospital, Creighton University, Omaha, NE.
Hemolytic uremic syndrome (HUS) is presenting itself as a serious health concern in children. HUS has primarily been linked to Escherichia coli O157:H7 infections, however, non-O157 strains are increasingly gaining attention as potential causative agents. Progression of illness may or may not be preceded by diarrhea. However hemolytic anemia, thrombocytopenia, and acute renal failure are the defining characteristics of the syndrome. The objective of this study is to investigate the cases of HUS at a regional Children's Hospital between 2001 and 2006 by retrospective chart review. A total of 44 cases were identified of which 57% were female and 43% were male with an age distribution of 13 months to 17 years. Data revealed 13 cases in 2006 compared to two cases in 2001 with 84% of all illnesses occurring in the summer and fall seasons. Fifty percent of all cases required dialysis for a mean of 5.9 days. Furthermore, stool cultures indicated E. coli O157:H7 as the predominant pathogen, however, 53% of the cases had no known etiology. Neurological complications occurred in 14% patients and pancreatitis in 29% of the cases with a female predominance. This data may suggest a growing number of cases and an increased role of non-O157 serotypes as an etiology.
FOLATE GENE POLYMORPHISM IN DOWN SYNDROME PATIENTS WITH ARTHRITIS
K Chastain, R Gaedigk, A Lasky, B Schindel, JS Leeder, M Becker. University of Missouri-Kansas City, Kansas City, MO.
Purpose: Down syndrome (DS) patients have had well-described toxicity to high dose methotrexate (MTX) in the oncologic literature. It has been hypothesized that the increased sensitivity to MTX in DS may be due to imbalances in nucleotide pools attributable to a gene dosage effect for enzymes encoded on chromosome 21. Low dose MTX is commonly used for arthropathy associated with DS. Genes for enzymes in the folate pathway have been investigated in rheumatoid arthritis to explain efficacy and toxicity with MTX. We investigated polymorphisms in the gene encoding solute family carrier 19 (SLC19A1) which is responsible for transporting MTX into the cell and located on chromosome 21, was of interest. Methods: JIA patients on a stable dose of MTX for 3 months or longer were consented for an extra 5 ml of blood during routine MTX lab monitoring as part of an IRB approved study evaluating MTX polyglutamation in JIA. DS subjects were identified within this cohort for further analysis. Demographics were collected by chart review, as well as efficacy and toxicity outcomes. Genomic DNA was extracted from whole blood with the Illustra RNAspin Mini RNA Isolation Kit (GE Healthcare) and amplified in gene specific PCR reactions. Subsequent genotyping of the PCR amplicons for SNPs in SLC19A1 was done by restriction fragment length polymorphism. Results: All three DS patient were heterozygous for SLC19A1 rs1051266 (80G ϾA). Side effects including nausea, emesis, and anxiety from methotrexate administration were significant in 1 out of the 3 patients and resulted in a decrease in methotrexate dose. All 3 patients required the addition of TNF inhibitors in addition to methotrexate for symptom control, and all three had continued active arthritis at evaluation. Conclusion: Methotrexate is a folate analog that enters the cell via SLC19A1, which is encoded on chromosome 21. It is hypothesized that a gene dosage effect exists for SLC19A1 in DS. The third copy of the gene on chromosome 21 may lead to increased enzyme activity and thus enhanced transportation of MTX into the cell, subsequently resulting in higher methylation demands which may lead to increased sensitivity to this medication in DS patients. However, all 3 patients required the addition of a TNF inhibitor and continued to have active arthritis, suggesting that at least in these patients, perhaps a third copy is inhibitory, and other factors beyond genotype are important contributors. Further analysis of the third allele via a copy number assay may elucidate allelic frequencies which may contribute to efficacy and toxicity in this population.
EFFECTS OF A UTERINE RESTRICTION MODEL ON FETAL KIDNEY DEVELOPMENT IN SHEEP
JM Habeck, SE Blohowiak, PP Kling, RR Magness. Pediatrics and Obstetrics, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Background: Fetal influences may alter the development of organs such as kidneys. A deficiency of kidney filtering units, nephrons, may ultimately result in hypertension as an adult. New nephrons develop until approximately 125 days gestation in sheep. A novel model of uterine size restriction and altered placental hemodynamics could be a tool to evaluate disturbances of fetal organ maturation. Purpose: We set out to determine whether uterine restriction will decrease fetal weight and disturb kidney nephron development in the sheep fetus. Methods: Before pregnancy, a unilateral horn of the uterus was tied off in mixed-breed sheep (unilateral restriction) and compared to controls. The sheep were bred and pregnancy timed. Lambs were delivered at 120 or 130 days gestation (term 145). Because relative kidney size differs between singleton and multiple gestations, only animals born as multiple gestations were studied. Fetal and kidney weights, and crown-rump lengths were determined and compared to normal (NL) values from the Magness Lab. Renal tissues were fixed and stained by H&E and Gomori trichrome for collagen. Histology was examined. Results: Weights from 15 control fetuses (1.006 ϫ NL) and 13 unilateral restriction fetuses (1.128 x NL) were equal and appropriatelysized for gestation, based on unpublished twin or triplet-specific normal values, p ϭ 0.15. Crown-rump lengths were similar. As a measure of lean body mass, the ratio of weight (kg)/crown-rump lengths (m) were not different (6.2 for controls and 7.1 for unilateral), p ϭ 0.15. Fetal kidney weight/fetal weight was lower in unilateral lambs, p Ͻ 0.01. Histology showed disturbed nephron development and increased collagen staining. Conclusion: The unilateral fetuses were not smaller with Mean weight numerically greater, but not different than control. However, offspring kidney development was disturbed with smaller kidneys and tissue fibrosis after unilateral uterine restriction. More studies are necessary to examine potential mechanisms involved. Helicobacter pylori has been recognized as a non-invasive microorganism causing gastric mucosal inflammatory and immune reaction. The gastric epithelium of H. pylori-infected individuals has been shown to have enhanced levels of several pro-inflammatory cytokines, including interleukin-1␤, IL-6, IL-8, and TNF-␣. Cytokine release is hypothesized to cause a substantial recruitment of inflammatory cells to the infected area, with subsequent release of reactive oxygen species (ROS). The ROS then cause the pathologic changes seen in the infected tissues. The increasing resistance to antimicrobials by H. pylori has resulted in the need for other agents to combat this bacterium. The antioxidant OptiBerry ® , which contains extracts of raspberry, strawberry, cranberry, elderberry, blueberry, and bilberry, was evaluated for its inhibitory effect on interleukin-6, IL-1␤, and TNF-␣ production in vitro. In this study, human gastric adenocarcinoma cells of the MKN-45 cell line (HAC) were examined for production of these cytokines when cocultured 1:10 with H. pylori and treated with OptiBerry ® . Results from this study indicate that MKN-45 cells infected with H. pylori reliably produced the cytokines IL-6, IL-1␤, and TNF-␣. In addition, OptiBerry ® was shown to reduce the levels of TNF-␣ production. However, OptiBerry ® had no statistically significant effect on IL-6 or IL-1␤ production by MKN-45 cells cocultured with H. pylori. It was concluded that there is a potential role for the antioxidant OptiBerry ® in therapeutic regimens for H. pylori infection.
IMPACT OF OPTIBERRY ® ON HELICOBACTER PYLORI-INDUCED CYTO-KINE PRODUCTION
CHOLINE AND GM1 GANLIOSIDE SUPPLEMENTATION ABOLISH THE ETHANOL INHIBITION OF L1 CELL ADHESION MOLECULE ACTIVA-TION OF EXTRACELLULAR SIGNAL-RELATED KINASES 1/2 (ERK1/2)
M He, N Tang, CF Bearer. Rainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, OH. Introduction: L1 cell adhesion molecule (L1) is critical for the development of the central nervous system. The neuropathologies of children with L1 mutations are similar to those with fetal alcohol syndrome implicating L1 as a target for ethanol toxicity. We have previously shown that ethanol inhibits L1 mediated neurite outgrowth and ERK1/2 activation of cerebellar granule neurons. Pharmacologic inhibition of ERK1/2 activation reduces neurite outgrowth of cerebellar neurons. Choline and GM1 ganglioside have been demonstrated to be protective against ethanol toxicity in recent studies. Objective: We sought to determine if choline and GM1 ganglioside can abolish the inhibition of ERK1/2 by ethanol and what is the most effective combination. Design/Methods: Cerebellar granule neurons, grown overnight in serum free media containing various concentrations of choline and GM1 ganglioside were treated with 25 mM ethanol for 1 h, and then activated with L1 clustering antibody for 10 min. The cell lysates were immunoblotted with anti-phospho ERK1/2, and then stripped and reprobed with anti-total ERK1/2. Results: Without GM1 ganglioside and choline (C/ GM1) supplementation, ethanol can significantly inhibit the ERK1/2 activation by ASCS4 (p Ͻ 0.05). With both 40 and 60 M C/GM1 in media, ERK1/2 activation was the same as control (p Ͼ 0.05). 20 M C/GM1 had no effect on ethanol inhibition whereas 80 M C/GM1 significantly protected against the ethanol effect, but not as well as 40 or 60 M. Conclusion: Choline and GM1 ganglioside abolish the ethanol effect on ERK1/2 activation in a dose dependent manner. Further research is needed to elucidate the underlying mechanism.
TOLUENE INHIBITS L1 CELL ADHESION MOLECULE SIGNALING
EA Kilbane, N Tang, V Avkshtol, M He, CF Bearer. Rainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, OH.
Background: Toluene is a commonly used organic solvent and an increasingly popular drug of abuse. Toluene abuse during pregnancy can result in a constellation of effects similar to fetal alcohol syndrome (FAS). Our previous studies have shown that inhibition of L1 cell adhesion molecule (L1) by ethanol has been implicated in the pathogenesis of FAS. We have shown that ethanol inhibits L1-mediated neurite outgrowth of cerebellar granule cells (CGN), L1 activation of extracellular signal related kinases 1 ⁄2 (ERK1/2), and dephosphorylation of tyrosine Y1176 in the cytoplasmic domain of L1. Due to the similarities between FAS and toluene embryopathy, we hypothesize that toluene and ethanol share similar mechanisms of toxicity. Objective: In this study, we examine the effects of pharmacological concentrations of toluene on the L1 mediated activation of ERK1/2 and dephosphorylation of Y1176 of L1 in rat postnatal day 6 cerebellar granule neurons (CGN). Design/Methods: CGN are plated on poly L-lysine and incubated overnight. Toluene dissolved in a vehicle of Alkamuls EL-620 (V) is added to the media for a final concentration of 10 mM, a concentration found in the blood of toluene abusers. Following a 1 h incubation, a monoclonal antibody to L1 crosslinked with mouse anti-IgG (ASCS4) is added to activate L1, and cells are harvested at 10 min. Cell lysates were immunoblotted for phosph-ERK1/2, total ERK, Y1176-L1 and total L1. Results: Toluene reduces L1 activation of ERK1/2 (P Ͻ 0.05) and dephosphorylation of tyrosine Y1176 of L1 (P Ͻ 0.05).. Conclusions: L1 may be a target for toluene developmental neurotoxicity.
SIGLEC-9 IS EXPRESSED ON CD34؉ CELLS FROM UMBILICAL CORD BLOOD AND ITS EXPRESSION INCREASES DURING NEUTROPHILIC DIF-FERENTIATION
K Knoedelseder, R Rashmi, N Panesar, MR Gartner, JM Koenig. Department of Pediatrics, Saint Louis University, Saint Louis, MO.
Background: Siglec-9 is a cell surface lectin shown to induce caspase-independent cell death in inflammatory adult neutrophils. Recently, surface expression of Siglec-9 was detected on a subset of acute myeloid leukemia (CD34-positive) cells, but was absent from normal adult bone marrow CD34-positive cells (Biedermann, 2006) . Based on our recent observation of higher surface expression of Siglec-9 in neonatal neutrophils compared with those of adults, we hypothesized that Siglec-9 might also be expressed in umbilical cord blood (UCB) CD34 cells and that its expression might vary with maturational stage. Objective: To evaluate surface expression of Siglec-9 on CD34 ϩ cells from umbilical cord blood and on HL-60 cells during neutrophilic differentiation. Design/Methods: CD34 ϩ cells were isolated from UCB by density centrifugation and immunomagnetic enrichment of mononuclear cells. Cells were stained with fluorochrome-labeled Mab to assess co-expression of Siglec-9 and CD34 and analyzed by multi-color flow cytometry. In parallel studies, HL-60 cells were differentiated towards the granulocytic lineage with 1.3% DMSO for 6 days. On progressive days of culture, aliquots of differentiating cells were stained for expression of CD34 and Siglec-9, and then analyzed by multi-color flow cytometry. Results: In 6 separate studies, we observed that 39 Ϯ 12% of UCB CD34 ϩ cells expressed surface Siglec-9; of these, 31.5% were CD34 lo Siglec-9 hi and 68.4% were CD34
hi Siglec-9 lo . During differentiation, HL-60 cells expressed generally increasing levels of Siglec-9, while expression of CD34 remained unchanged over a 6-day course. Conclusions: We observed a prominent surface expression of Siglec-9 on UCB CD34ϩ cells, which was reportedly absent from CD34ϩ cells in adult bone marrow. In addition, we determined that surface Siglec-9 expression increased during terminal neutrophilic differentiation. These and our previous studies suggest that Siglec-9 expression is dependent on the developmental stage of the host in hematopoietic cells, and that it may have a unique contribution to myeloid function in neonates.
EARLY EXTUBATION AND HIGH FLOW NASAL CANNULA AFTER SUR-FACTANT TREATMENT FOR RESPIRATORY DISTRESS AMONG PRE-TERM INFANTS
J Aguila-Corrales, Marc Weiss. Loyola University Medical Center, Maywood, IL.
Objective: 1) To retrospectively review the outcome and success rate of early extubation and humidified high flow nasal cannula after surfactant treatment for RDS among preterm infants 24 to 35 weeks gestation. 2) To determine at which gestational age it would reasonable to attempt early extubation. Methods: Charts of infants admitted to Loyola University Medical Center Neonatal Intensive Care Unit (LUMC NICU) between January to December 2006 with gestational age 24 to 35 completed weeks were reviewed. Those treated with intratracheal Curosurf® within two hours of birth, extubated within 48 hours of life, and survived until the time of discharge were included in the study. The study group was divided based on gestational age, 24 -25 weeks, 26 -27 weeks, 28 -29 weeks, 30 -31 weeks, 32-33 weeks, and 34 -35 weeks. Exclusion criteria include major congenital anomalies and a 5 minute Apgar score Ͻ 5. The four variables specifically analyzed as predictors of early extubation were, 1) gestational age (GA), 2) number of surfactant doses, 3) doses of antenatal steroids (Betamethasone), and 4) Apgar score at 5 minutes of life. This retrospective observational study was analyzed using logistic regression. Results: A total of 88 infants fulfilled the criteria of the study: 24 -25 weeks (n ϭ 7); 26 -27 weeks (n ϭ 21); 28 -29 weeks (n ϭ 16); 30 -31 weeks (n ϭ 17); 32-33 weeks (n ϭ 12); and 34 -35 weeks (n ϭ 15). Of the four variables analyzed, GA the most statistically significant with a P value Ͻ 0.05. Successful extubation (defined as not requiring reintubation up to the time of discharge) at 24 -25 weeks was (1/7) 14%, at 26 -27 weeks (14/21) 67%, 28 -29 weeks (15/16) 94%, 30 -31 weeks (13/17) 76%, 32-33 weeks (12/12) 100%, 34 -35 weeks (15/15) 100%. Conclusion: GA remains the most statistically significant among the predictors of early extubation. The earliest attempt of early extubation with a success rate of 66% in this study was between 26 -27 weeks. At 28 -29 weeks, the success rate of early extubation is 94%.
ORAL FEEDING DIFFICULTY AT NICU DISMISSAL: A MARKER OF LATER DISABILITY IN PRETERMS?
S Allen. Developmental Pediatrics, University of Kansas Medical Center, Kansas City, Kansas; C Castor, C Lambrecht, HW Kilbride, Neonatology, University of Missouri -Kansas City, Kansas City, MO.
Purpose: This preliminary study investigates whether preterm infants with oral feeding difficulty (OFD) at intensive care nursery (NICU) dismissal manifest developmental delay by early childhood. Methods: OFD was retrospectively defined by use of feeding tube, and/or feeding more often than every 3 hours, and/or use of formula concentration exceeding 24 kcal/ounce at NICU dismissal. Participants were chosen from a clinic database of 328 infants, born at Յ32 weeks gestation who were dismissed from NICU between 2002 and 2004. 71 patients with OFD were identified (22% of database) and matched by birth weight (BW) and gestational age (GA) to 71 controls. These families were contacted in follow-up; responders included subjects with (n ϭ 29) and without (n ϭ 31) OFD, age between 43 and 81months (mean 59.5). Families were interviewed by phone using the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) plus a short questionnaire. Standard scores were calculated, and group comparisons were analyzed by chi-square and univariate analysis of variance with significance indicated by P Ͻ .05. Results: There were no group differences between OFD and control in BW (1044 Ϯ 379g vs.1052 Ϯ 310g), GA (28.1 Ϯ 2.4wk vs. 27.4 Ϯ 1.9wk), grade III-IV intraventricular hemorrhage, retinopathy of prematurity requiring surgery, or supplemental oxygen at 36 weeks GA. OFD subjects were more likely receiving occupational therapy at early childhood (p ϭ .01). However, there were no differences in VABS-II domain scores of Communication (92 Ϯ 17 vs. 93 Ϯ 12), Daily Living Skills (85 Ϯ 15 vs. 89 Ϯ 15), Social (81 Ϯ 10 vs. 82 Ϯ 12), Motor (85 Ϯ 16 vs. 86 Ϯ 18), or any subdomain scores. Most OFD subjects (22/29) left NICU with feeding tube; VABS-II scores of these 22 subjects were also no different than controls. 5/29 OFD subjects (17%) still used feeding tube by early childhood, and VABS-II scores for these five children were significantly lower in all VABS-II domains except for socialization (p ϭ .07). Conclusion: OFD is prevalent in preterms at NICU dismissal. However, OFD subjects did not differ from controls in adaptive behavior scores by early childhood. In this small sample, 17% of those discharged from the NICU with a gastrostomy tube still required device support for nutrition, and this subgroup of patients differed markedly in adaptive behavior scores compared to controls.
EPIDEMIOLOGY AND OUTCOME OF PNEUMOCOCCAL MENINGITIS IN THE ERA OF PCV7
TG Hall, AL Myers, MA Jackson, R Selvarangan. SS Simon Children's Mercy Hospitals & Clinics, University of Missouri-Kansas City, Kansas City, Missouri.
Background and Study Purpose: Pneumococcal meningitis (PM) remains the most common cause of pediatric meningitis despite the advent of PCV7. Hearing loss remains the most common sequelae. An increased risk has been noted in children who have a short interval between first vancomycin (VAN) after ceftriaxone (CTRX) dosing. A single center retrospective observational study was undertaken to investigate the epidemiology of PM and evaluate the association between VAN and CTRX dosing and hearing loss. Methods: Medical records of all children were reviewed from our urban tertiary care center with ICD-9 codes for PM from 1/95-9/07. Chart review included demographics, underlying disease, antibiotic susceptibility, neurologic presentation, and outcome including death, hearing loss, or other deficit. Dosing interval was recorded as Յ120 min. or Ͼ120 min. for VAN after CTRX. Results: 59 cases of PM occurred in the study period; 4 died (6.8%). Hearing evaluations were available for 54/55 (98%). Overall, 15 (27%) had hearing loss, 9 profound; 14/15 had dosing interval data available. Dosing intervals among those with hearing loss were Յ 120 min in 6 (43%) and Ն 120 min in 8 (57%). Odds ratio for hearing loss with short dosing interval was 1.08 . Odds ratio for presence of underlying disease was 2.37 Background: Asthma prevalence has increased dramatically over recent decades, demonstrating that environmental factors may play a critical role. Previous studies have assessed the influence of diet and nutrition on the risk of acquiring childhood asthma, on asthma severity and on pulmonary function. Notably, positive associations have been found between some vitamins (e.g., ascorbic acid, ␣-tocopherol, and ␤-carotene) and pulmonary function in adults and adolescents. Vitamin D (Vit D) status may also have a role in the etiology of asthma. In experimental models, calcitriol has been shown to decrease pro-inflammatory cytokine production and promote anti-inflammatory pathways. Prior analysis of the National Health and Nutrition Examination Survey (NHANES) III found a strong positive association between Vit D status and pulmonary function in adults. However, similar analyses in children and adolescents have not been performed. Methods: This study evaluated associations between Vit D status, determined by serum levels of 25(OH)Vit D, and the prevalence and severity of asthma. We selected respondents between 6 and 20 with current asthma symptoms from the 2001-2004 NHANES III dataset. An asthma severity score (mild vs. moderate/severe) was developed using variables of recent asthma exacerbation, wheezing episodes, medical doctor and Emergency Department visits. Asthma (n ϭ 614) and non-asthma cohorts (n ϭ 5,606) were compared on serum levels of 25(OH)Vit D using surveyweighted chi-square tests and multivariable logistic regression models that included BMI and racial demographics. Results: Asthma rates were highest in the children age 6-9 and 9-12 years with 25(OH) Vit D levels Ͻ 10 ng/dl (33.2% and 22.8%, respectively), however the numbers of subjects in these groups were small and associations did not reach statistical significance (P ϭ 0.35 and 0.24, respectively). The prevalence of asthma in all ages defined by 25(OH)Vit D deficiency (Ͻ 20 ng/dl) were 28.2% in the moderate/severe, and 22.8% in the mild category, however still not significant (P ϭ 0.25). BMI and darker-pigmented races (African-and MexicanAmerican) were strongly associated with decreased 25(OH)Vit D levels (P Ͻ 0.001). Conclusion: There is a trend between low Vit D status, increased asthma risk and asthma severity, but the small number of young asthma subjects in the 2001-2004 NHANES dataset limits statistical analysis. Further studies utilizing different sampling methods are needed to further evaluate this relationship.
RESPIRATORY SYSTEM COMPLIANCE IN PREMATURE INFANTS IN RE-LATION TO ANTENATAL STEROIDS AND AS A GUIDE TO EXTUBATION
S Chawla, G Natarajan, J Cortez, J Lua. Wayne State University, Detroit, MI.
Background: Premature infants with respiratory distress syndrome (RDS) are known to have poor respiratory compliance. Antenatal Steroids (ANS), administered in 2 doses, 24 hours apart have been shown to reduce the incidence of RDS. Whether this effect is primarily due to improvement in pulmonary mechanics is unclear. Our objectives were to examine the effect of varying timing of ANS exposure on respiratory compliance of premature infants and to evaluate measures of pulmonary mechanics in the prediction of successful extubation. Methods: Respiratory compliance (Crs) was measured in preterm infants (n ϭ 60) born prematurely (Յ32 weeks) gestation and requiring ventilator support, within the first 6 hours of life prior to surfactant administration. Infants were divided in three groups based upon the dose and timing of ANS exposure; Group 1(0 to 1 dose), Group 2(2 doses 24 hours to 14 days prior to delivery) and Group 3(2 doses Ͼ 14 days prior to delivery). Multiple measures of pulmonary mechanics were done within 6 hours prior to elective extubation before 3 weeks of age to predict success of extubation. Results: The mean birth weight and gestational age were higher in Group 3 compared to groups 1 and 2, 1239 gm (334) vs. 987 gm (419) and 915 gm (385) p ϭ 0.029 and 29 weeks (2.2) vs. 27 weeks (2.7) and 27 weeks (2.8), p ϭ 0.034. Respiratory compliance (Crs/birth weight) was significantly higher in group 2: 0.65(0.26), compared to groups 1 and 3: 0.34 (0.09) and 0.44 (0.20)ml/cmH 2 O/Kg (p ϭ 0.001). Neither the ratio of spontaneous to total minute ventilation on endotracheal CPAP nor compliance prior to extubation were significantly different among those who were successfully extubated compared to those who failed. Among 31 infants who passed the spontaneous breathing test, 28 (90.3%) were successfully extubated. Three (75%) of those who failed the spontaneous breathing test also failed extubation (p ϭ 0.004). Conclusion: Compliance soon after birth was significantly improved among premature infants whose mothers were administered a complete course of antenatal steroids within 2 weeks of delivery despite lower gestation and birth weight compared to no/partial or distantly administered ANS course. The spontaneous breathing test prior to extubation may be a useful adjunct to predict successful extubation in premature infants with RDS.
SYMPTOMATIC SPONTANEOUS PNEUMOTHORAX IN TERM NEWBORN INFANTS: ALWAYS A BENIGN ENTITY?
J Smith, RE Schumacher, S Sarkar. Department of Pediatrics, C.S. Mott Children's Hospital, University of Michigan Health System, Ann Arbor, Michigan.
Background: Spontaneous pneumothoraces in newborns who have never been exposed to positive pressure ventilation and were without obvious pulmonary pathology often present soon after birth with varying degrees of respiratory distress. Not much however is known, as to how they should be managed and their outcomes. The purpose of this observational study was to characterize the clinical course and the outcome of the term newborn infants with spontaneous pneumothoraces. Methods: Retrospective review of term newborn infants with symptomatic pneumothoraces born between January 2002 and December 2006.
Results: Two hundred thirty-seven full-term and near-term infants were identified with symptomatic pneumothoraces: Sixty-two (26%) infants had spontaneous pneumothoraces, and the remaining 175 infants had obvious pulmonary pathology e.g. congenital diaphragmatic hernia, meconium aspiration syndrome etc., and/or were exposed to or receiving mechanical ventilation at the diagnosis of pneumothoraces. Forty-one (61%) of the 62 infants with spontaneous pneumothoraces could be managed conservatively while 21 required surgical interventions in the form of thoracocentesis or/and thoracostomy drainage. Resolution of symptoms occurred in 1 day (median, range 1-2 days) in infants managed conservatively and 2 days (median, range 1-12 days) in infants requiring surgical intervention. Indications for surgical interventions in these 21 infants were: development of persistent pulmonary hypertension (PPHN) during conservative treatment in 9, imminent transport prompting elective evacuation of air at the referring hospital in 7, progressive deterioration in respiratory status with underlying pneumonia in 3 and without pneumonia in 2 infants including 1 infant who had tension pneumothorax. Thirteen of these 21 infants requiring surgical intervention needed mechanical ventilation and 3 infants subsequently required ECMO. Conclusions: Majority of term and near-term infants with spontaneous pneumothorax has a benign course with good outcome, and can be managed conservatively. Presence of PPHN or underlying pneumonia in newborns diagnosed to have spontaneous pneumothorax should prompt referrals to tertiary level neonatal units in anticipation of the need for surgical interventions and mechanical ventilation.
PDA LIGATION IN PRETERM INFANTS: A SETBACK, AT LEAST TEMPO-RARILY
S Chawla, S Aggarwal,and, G Natarajan. Wayne State University, Detroit, MI.
Background: There is growing uncertainty about the value of ligation of patent ductus arteriosus (PDA) among premature infants. While generally considered a safe surgical procedure, the postoperative effects of surgical ductal ligation have not been previously studied. We hypothesized that surgical ligation of PDA is associated with considerable short-term cardio-respiratory morbidities. Methods: A retrospective chart review was performed on preterm infants Յ 28 weeks gestation who underwent PDA ligation. Demographic data, details of pre and post-operative clinical course and outcomes were abstracted. Statistical analysis (SPSS software) included chi-square test for nominal variables and t test for categorical variables. Results: Our cohort (n ϭ 82) had a median (range) gestational age of 25.5 (23-28) weeks and birth weight 765 (485-1150) grams; 51 (62.2%) were males. The median (range) age at diagnosis and ligation of PDA was 6 (2-23) days and 21(5-58) days. Primary ligation was performed in 28 (34.1%) infants. At 48 hours following ligation, an increase in FiO2 was needed in 49 (60%) infants and in the ventilatory support in 35 (43%) infants. Pressors were administered in 15 (17.9%) cases. An increase in respiratory or pressor support was required in 53 (64.6%) infants. Pneumothorax developed in 18 (22%) cases while X-ray findings worsened in 36 (44%) infants. The median (range) duration to return to baseline FiO2 was 3(1-30) days, to extubation was 16 (1-98) days and to start feeds was 3 (1-17) days. Post-operative outcomes did not differ significantly between the primary ligation and medically treated groups. Nine (11%) infants died, 35 (42.4%) had moderate or severe bronchopulmonary dysplasia, 30 (37%) had severe intraventricular hemorrhage (Grade 3-4) and 16 (20%) developed necrotizing enterocolitis. Conclusion: PDA ligation in extremely preterm infants is associated with an increase in cardio-respiratory support in the immediate post-operative period in the majority. Whether the setback is temporary or adversely affects long-term outcomes remains to be determined.
OUTCOMES IN INFANTS WITH CARDIAC DYSFUNCTION ASSOCIATED WITH BRONCHIOLITIS
C Stickney, K Mason. Department of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, OH.
Background: Although bronchiolitis is a common cause of Pediatric Intensive Care Unit (PICU) admission in infants, associated cardiovascular dysfunction has only infrequently been reported in the literature. These isolated reports, the largest of which is a case series of eight patients with complex atrial tachycardias, describe cardiac abnormalities in patients with acute bronchiolitis including dysrhythmia and myocardial dysfunction. Because of the rarely described occurrence of acquired heart disease in this patient population, little can be stated regarding the implications for morbidity, mortality, or recurrence of cardiac dysfunction in these patients. Our purpose is to examine the presentation, hospital course, status at discharge, and, when available, long-term outcomes of infants with bronchiolitis and evidence of cardiac dysfunction admitted to the PICU at Rainbow Babies and Children's Hospital. Methods: We undertook a single-institution retrospective chart review of infants admitted to the PICU from January 1, 1998 to March 1, 2008 with a diagnosis of bronchiolitis who developed cardiovascular dysfunction as manifested by 1) hypotension requiring any combination of inotropes, vasopressors or extracorporeal membrane oxygenation (ECMO) support; 2) echocardiographic evidence of myocardial dysfunction or morphologic changes; or 3) cardiac arrhythmias. Results: Five infants were identified from the ten-year period reviewed. Two infants presented with supraventricular tachycardia requiring anti-arrhythmics and/or cardioversion. One infant had documented right ventricular hypertrophy which had resolved on follow-up echocardiogram three months following discharge. Two infants developed hypotension requiring inotropic support. These two infants had complete resolution of dysfunction at the time of hospital discharge. Two other infants were discharged on cardiac medications; one was subsequently lost to follow-up while the other was ultimately diagnosed with Wolff-Parkinson-White syndrome. There were no case fatalities in our cohort. Conclusions: During the past decade, cases of bronchiolitis-associated cardiac dysfunction at Rainbow Babies & Children's have been rare. Of note, this series includes the first description of an infant presenting with reversible changes in cardiac morphology in the setting of RSV bronchiolitis. Additionally, we describe the first presentation of an infant with previously-unknown WPW and onset of SVT precipitated by bronchiolitis. This singleinstitution case series of five patients contributes further data to the body of extant literature describing bronchiolitis-associated cardiovascular dysfunction.
DESCRIPTION OF A NEWLY INSTITUTED ANTIMICROBIAL STEWARD-SHIP PROGRAM
J Newland, L Stach, MA Jackson. Children's Mercy Hospital (CMH), Kansas City, MO.
Background: The Infectious Diseases Society of America established guidelines for antimicrobial stewardship programs (ASP). The guidelines request research on ASP strategies in pediatrics. Methods: A prospective study was begun to evaluate the ASP at CMH. On 3/3/08 a prospective audit ASP was implemented. The antibiotics (abs) audited: 3 rd gen cephalosporins, cefepime, ␤-lactam/␤-lactamases, vanc, linezolid, meropenem, amikacin, tobramycin, aztreonam & fluoroquinolones. Data is collected on patients (pts) that receive a monitored ab for 2 days. Results: 860 pts and 988 monitored abs were reviewed from 3/3 to 5/31/08. The ab most frequently reviewed was ceftriaxone/cefotaxime 487. Services most often ordering a monitored ab were general peds 170, heme/onc 144, & hospitalist 141. The indications for using abs were presumed sepsis 198, and pneumonia 113. 311 recommendations were made on 237 (28%) pts. Compliance occurred in 94% of pts. Conclusions: A prospective-audit with feedback ASP has been successfully implemented and accepted in a children's hospital. Discontinuing therapy, shortening duration, and narrowing therapy were the most frequent recommendations and likely will affect cost savings and ab resistance. 
NEONATAL-PERINATAL RISK FACTORS IN LENTICULOSTRIATE VAS-CULOPATHY
S Szkola, E Malone, A Kuder, R Mittendorf, J K Muraskas. Loyola University, Maywood, Illinois. Background: Lenticulostriate vasculopathy is a mineralizing vasculitis confined to the blood vessels of the thalami and basal ganglia of newborns. The incidence is 1-3% with no known etiology. LSV most often is an incidental finding on routine cranial ultrasounds of preterm newborns. Neurodevelopmental sequelae appear to be minor. Grey matter lesions are atypical in preterm newborns compared to the vulnerable periventricular white matter. Study Design: Over a 10 year period (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) , we retrospectively identified 28 preterm newborns with the diagnosis of LSV on routine cranial ultrasounds prior to discharge from the NICU (Group 1). In this same period, we identified 40 preterm newborns without LSV as controls (Group 2). We examined the general characteristics of gestational age and birthweight, as well as antenatal variables of multiple gestation, antenatal steroid use, preeclampsia, tobacco use, chorioamnionitis and MgSO 4 exposure. Postnatal factors investigated were one and five minute APGAR scores, early hypotension, hypoglycemia, initial blood gas values, IVH (grade III and IV), PDA (treated), presence of NEC (stage 2ϩ), and chromosomal abnormalities. Statistical significance was determined by Fisher Exact test and t-test. Results: The LSV group (Group 1) and control (Group 2) were similar in gestational age at 28.9 Ϯ 3 and 28.3 Ϯ 4.3 weeks respectively with mean birth weight at 1404 Ϯ 766 and 1277 Ϯ 590 grams respectively. Of the antenatal variables, the LSV group had significantly less exposure to antenatal steroids, more magnesium tocolysis and a higher incidence of chorioamnionitis. Among postnatal variables, the LSV group had significantly more neonates with an initial ABG demonstrating pH Ͼ 7.4 and pCO 2 Ͻ 30. Conclusion: Our findings suggest that LSV is associated with decreased antenatal steroid use, increased magnesium sulfate tocolysis, chorioamnionitis, and early respiratory alkalosis in preterm newborns. Pseudomonas aeruginosa (PA) is a gram negative bacterium that causes morbidity in children with cystic fibrosis and those with neutrophil dysfunction. Appropriate therapy depends on accurate susceptibility testing. Recent studies question the accuracy of beta-lactam susceptibility results for PA when tested by automated systems. The purpose of this study was to compare the accuracy of an automated testing system, Vitek 2 to disk diffusion (DD) method and to classify discrepant results. Methods: This study used 39 PA isolates (15 blood, 10 respiratory, and 14 wound/body fluid specimens) obtained from children between 3/06-8/07. Antimicrobial susceptibility data were analyzed by comparing the historical results from Vitek 2 to those by DD testing against 5 beta-lactams (cefepime, ceftazidime, imipenem, piperacillin-tazobactam and aztreonam). Discrepancies between test results were categorized as minor, major or very major errors. When compared to DD, a false-susceptible and false-resistant result from Vitek 2 was classified as very major error and major error respectively. A minor error denotes an intermediate test result from Vitek 2 or DD when the other test result was susceptible or resistant. Conclusion: While the very major error rate for imipenem and piperacillin-tazobactam is lower than prior studies, it may be prudent to exercise caution when interpreting results obtained from automated system for these two agents. The data from this study suggests that Vitek 2 is generally a reliable method to determine antimicrobial susceptibilities for PA. The objective of this research is to estimate the cost-benefit ratio of universal meconium screening for maternal drinking. Fetal alcohol spectrum disorder (FASD) and its subset fetal alcohol syndrome (FAS) are preventable and remain a public health tragedy. The incidence of FAS and FASD have been conservatively estimated to be 0.97 per 1000 and 10 per 1000 births, respectively. Meconium testing has been demonstrated a promising at-birth detection method of drinking during pregnancy. Method/Design: The current costs of FAS and FASD, alcohol treatment programs, and meconium screening were estimated by literature review. Monetary values were converted roughly to equal dollars in 2006. Costs of meconium analysis as an additional part of the current newborn screening program and treatment for the identified mothers were estimated and compared to the potential averted costs that may result from identification and intervention for mothers. Three potential maternal treatment strategies, residential, pharmacologic and brief telephone interview, are analyzed. Results: Depending on the treatment type, the savings may range from $5 to $115 for every $1 spent on screening and treatment. Conclusion: We suggest that a universal meconium screening at birth to identify high-risk women and prevent the future costs of FASD be considered. Future research should be directed at improving detection and interventions as well as considering the ethical issues involved in such a screening program. Background: Persistent pulmonary hypertension of the newborn (PPHN) remains one of the major causes of death in infants with meconium aspiration syndrome (MAS).At present there is no tool to predict development of PPHN in MAS. Objective: To predict development of Persistent Pulmonary Hypertension (PPHN) in Meconium Aspiration Syndrome (MAS) and to explore the possible Pathogenesis. Design/Methods: We retrospectively analyzed 114 infants who were admitted to our NICU because of MAS between Jan 2002-Oct 07 .MAS was diagnosed based on 1) Meconium staining of amniotic fluid 2) Respiratory distress and 3) Positive chest radiographs. PPHN was diagnosed by pediatric cardiologist based on Echo evidences of pulmonary hypertension and with right to left shunt through Foramen Ovale and/or ductus-arteriosus without other anatomic abnormalities. All infants followed a respiratory protocol in NICU. Results: Of the 114 newborns with MAS, 23 had PPHN (20.2%). Time of onset of PPHN: 6(26%) at Ͼ 24 hrs, 12(52%) at 12-24 hrs and 5 (22%) at Ͼ 24 hrs of postnatal age. All 23 infants required NO therapy, 3 required HFOV and 4 required ECMO.When compared infants with and without PPHN, the risk factor for PPHN include: outborn neonatal transfer (14/23 vs 32/91 p ϭ 0.023), low initial pH (mean Ϯ SD 7.19 Ϯ 0.16 vs 7.29 Ϯ 0.15 p Ͻ 0.01 ) lower PaO2 ( 64 Ϯ 25 vs 113 Ϯ 55mmHg p Ͻ 0.05), high PCO2 ( 51 Ϯ 12 vs 43 Ϯ 14mmHg p Ͻ 0.05), and higher proportion of hypocalcemia (Ͻ 6.5 mg %) (8/23 vs 7/86 p Ͻ 0.01) on admission to NICU. There is tendency for higher incidence of maternal fever and foetal distress in infants with PPHN. Conclusions: Mortality can be reduced in MAS cases by managing all MAS cases with the initial lower PaO 2 , pH, and Calcium in high dependency unit Considering, positive co-relation between these factors with MAS and development of PPHN.
TO PREDICT DEVELOPMENT OF PERSISTENT PULMONARY HYPER-TENSION OF NEWBORN IN CASES OF MECONIUM ASPIRATION SYN-DROME (MAS)
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WOULD PROPHYLACTIC PDA TREATMENT DECREASE HOSPITAL RE-SOURCES UTILIZATION?
MA Attar, V Bhatt-Mehta, S Hiebert, RE Schumacher. University of Michigan, Ann Arbor, MI.
Introduction: Patent ductus arteriosus (PDA) and its treatment are associated with multiple serious complications in very low birth weight (VLBW) infants. Methods: We evaluated the effect of prophylactic PDA treatment on the utilization of hospital resources in a regional neonatal intensive care unit (NICU). We retrospectively analyzed data including hospital length of stay (LOS) from medical record. We also compared observed LOS to predicted LOS (calculated and reported by the Vermont Oxford Network (VON) using a multivariate analysis, accounts for many variables contributing to variability in LOS). Prophylactic treatment within the first 24 hours of life with Indomethacin was used between September 2006 and April 2007. Infants born between January 1, 2005 and April 30, 2007 with gestational ages less than 28 weeks, survived for more than two days were included in the analysis. Results: Seventy nine patients met the study criteria, 20 received Indomethacin prophylactic treatment and 59 received no prophylactic treatment. Infants treated prophylactically had similar gestational age (median, IC range); 26 (24-27) vs 26 (23-27) weeks but higher birth weights (mean, SD); 890 (219) vs 838, (198) p ϭ 0.047 compared to untreated infants. The two groups had similar rates of prenatal treatment with steroids, treatment with surfactant, male gender, mortality and being born at a tertiary center. The two groups also had similar duration of support with mechanical ventilation. Treated and untreated infants died before hospital discharge had similar NICU LOS (mean, SD); 19 (25) vs 20 (15) days. Prophylactically treated infants needed rescue PDA pharmacologic treatment less frequently (20% vs 63%, p ϭ 0.002) but had similar rates of surgical ligation (30% vs 29 %) compared to untreated infants. Prophylactically treated infants also had significantly higher rates of intestinal perforation (30% vs 7%, p ϭ 0.014) and abdominal surgeries (30% vs 8%, p ϭ 0.03) and had a higher rate of necrotizing enterocolitis (20% vs 14%, p ϭ 0.49) that was not statistically significant compared to untreated infants. Infants survived to discharge to home (17 treated and 45 untreated) had a similar total observed LOS (mean, SD); 89 (29) vs 96 (32). However, infants prophylactically treated with indomethacin had a clinically important larger difference between observed and predicted LOS (mean observed-predicted, SD) 10 (17) vs1 (45) than untreated infants, but that difference was not statistically significant, p ϭ 0.14. Conclusions: Prophylactic PDA treatment with Indomethacin was associated with more abdominal surgeries. The independent effect of prophylactic PDA treatment on LOS should be included in assessing the efficiency of such a treatment. Background: Wide variation exists in the treatment of suspected GERD in premature infants; it is unknown to what degree diagnostic and treatment choices are impacted by the treating physician's medical specialty or impression of the medical literature. Methods: We conducted an online survey of board-certified neonatologists, pediatric pulmonologists, and pediatric gastroenterologists about their beliefs regarding the symptoms, diagnosis and treatment of GERD in premature infants in the NICU, based on both clinical impression and assessment of the literature. Results: 1021 neonatologists, 232 pediatric pulmonologists, and 222 pediatric gastroenterologists participated in the study (47.5% response). There was disagreement among specialties in nearly all aspects of the survey. Pulmonologists were most likely to report that respiratory symptoms are caused by GERD (p Ͻ 0.001). Neonatologists were least likely to report that a therapeutic trial of pharmacologic agents would be useful for diagnosing GERD (p Ͻ 0.001) or that lansoprazole, ranitidine, or cimetidine are safe or effective (p Ͻ 0.001). No pharmacologic therapy had Ͼ50% of respondents supporting its effectiveness. There was only moderate correlation between physician belief based on the medical literature and belief based on clinical impression (Spearman Rank Correlation 0.47-0.75). For therapies supported by multiple randomized controlled trials (RCT's) in infants vs. therapies with fewer RCT's in infants, physicians rated the evidence for effectiveness similarly. Conclusion: There is wide variation within and between pediatric specialties with regard to attitudes and beliefs about suspected GERD in premature infants, as well as about the weight of evidence in the medical literature for this patient population. Furthermore, there is no agreed-upon standard of care. Greater understanding is needed about the way in which physicians process evidence from the medical literature.
DIFFERENCES IN BELIEF AMONG PEDIATRIC SPECIALISTS REGARD-ING GASTROESOPHAGEAL REFLUX DISEASE (GERD) IN PREMATURE INFANTS IN A NEONATAL INTENSIVE CARE UNIT SETTING: CLINICAL VIEWS AND IMPRESSIONS OF THE MEDICAL LITERATURE
